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Abstract 
 
The recovery movement presents a shift in the treatment of severe mental illness to a 
more person-centered approach.  The current researcher hypothesized that the more 
recovery-oriented a treatment was perceived to be, the more participants would have 
attended appointments and adhered to their psychiatric medication regimen.  The 
variables of empowerment, recovery assessment, attitudes toward treatment, and 
participatory decision-making were explored in relation to their possible correlation with 
increased treatment adherence.  An archival data set was used.  Participants included 215 
adults who met criteria for a schizophrenia spectrum disorder.  The participants generally 
rated their treatment as high on all four of the recovery measures, and treatment 
nonadherence was not particularly problematic for the sample explored in the current 
study.  Participants’ reports of increased symptom severity and reports of positive quality 
of life were found to be associated with higher reported levels of appointment attendance.  
Participants’ reports of positive attitudes toward psychiatric treatment were found to be 
associated with reports of better quality and frequency of medication adherence.  
Measuring whether treatment is recovery-oriented may not be predictive of patients’ 
levels of service engagement.  Recommendations for future research include using 
additional and qualitative measures to capture the full construct of service engagement, 
beyond measures of treatment adherence.  Additionally, recovery-oriented treatment is 
aimed to be individualized; therefore, studies measuring the recovery-orientation of a 
treatment provider should include alternative treatments used to enrich the lives of the 
patients. 
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 Chapter 1: Introduction 
Nonadherence to treatment is a widespread problem in general medical 
populations, as well as among individuals with mental-health problems (DiMatteo, 
Giordani, Lepper, & Croghan, 2002), and especially among those who have been 
diagnosed with a schizophrenia spectrum disorder (Coldham, Addington, & Addington, 
2002).  There are different types of treatment adherence, such as taking medication as 
prescribed, attending scheduled appointments, and complying with recommendations 
made by clinicians (Dolder, et al., 2004; Valenstein et al., 2002). 
            Nonadherence to psychiatric medication and mental-health appointments has been 
found to be associated with increased and longer psychiatric hospitalizations in people 
with schizophrenia spectrum disorders (Dolder et al., 2004; Valenstein et al., 2002).  
Dolder et al. (2004) found that nonadherence was also associated with increased 
hospitalizations for medical reasons in this population.  Consequently, identifying 
transformable predictors associated with nonadherence is important in order to increase 
the likelihood that people with schizophrenia spectrum disorders will find mental-health 
treatment a viable means of decreasing their symptoms and increasing their quality of 
life. 
            Many variables have been examined regarding nonadherence to psychiatric 
medication, including patient-, environment-, physician-, and treatment-related variables 
(Oehl, Hummer, & Fleischhacker, 2000).  Examples of patient factors include 
socioeconomic status and other demographic variables.  Environmental factors can 
include social stigma toward psychiatric treatment surrounding the mentally ill individual 
and the stigma surrounding the specific illness.  Examples of physician factors are the 
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doctor-patient relationship and how such relationships have been affected by the 
physician’s dedication of time to discuss the subjective needs of the patient, including 
possible side effects of medication.  Examples of treatment factors include those 
associated with medication, for example, the severity of possible side effects, the delayed 
beneficial effect of the medication, the route of medication administration, and the 
complexity of the regimen (Oehl et al., 2000).  The investigation into the correlates of 
treatment adherence has shifted over the years towards variables more representative of 
social and physician factors rather than of the historically predominant focus on patient 
factors.  This shift occurred concurrent with the growth of patient-centered care 
approaches in general medicine and the transformation of mental-healthcare systems 
towards recovery-oriented care. 
            The recovery movement in mental-healthcare has provided a framework for a 
person-centered treatment approach in which the focus of treatment is to be inclusive of 
the patients’ preferences and personally relevant goals.  The recovery framework 
involves a shift away from a medical treatment model to a treatment philosophy that 
involves individuals, their families, and communities.  This framework focuses on 
instilling hope, encourages advocacy, and provides education about all available 
treatment approaches (Glynn, Cohen, Dixon, & Niv, 2006).   
 The recovery-oriented variables examined in this study are empowerment, 
participatory decision-making (PDM), attitudes toward treatment, and other factors 
measured by the recovery assessment scale (eg., hope, willingness to ask for help, 
importance of support networks, and desire and ability to accomplish goals).  These 
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variables are explored in relation to their possible correlation with increased treatment 
adherence. 
The purpose of the current study is to examine variables that reflect a person-
centered approach to psychological care that are predictive of higher levels of treatment 
adherence for people with schizophrenia spectrum disorders.  The variables associated 
with the recovery movement, empowerment, and PDM have been found to be associated 
with reductions in positive symptomatology and rehospitalization and with better overall 
outcomes (Deegan & Drake, 2006; Dickerson, 1998).  Recovery-oriented variables, 
including attitudes toward treatment, recovery assessment, empowerment, and PDM, are 
examined to determine if they are associated with greater medication adherence and 
higher levels of consistency with attending psychiatric appointments.  If these variables 
are found to be associated with increased treatment adherence, this information can be 
utilized to improve mental-health treatment for people with schizophrenia spectrum 
disorders by directing treatment to be oriented more towards recovery principles and by 
informing physicians, psychiatrists, families of consumers, and consumers themselves of 
the benefits associated with this treatment approach. 
Definition of Treatment Nonadherence 
Nonadherence to treatment regimens is a vast problem in general healthcare, as 
well as in psychiatric healthcare.  Increasing treatment adherence has been identified as 
one of the most direct ways to eliminate symptom exacerbation, rehospitalization, and 
relapse, and to improve overall prognoses for chronic conditions, including psychotic 
disorders (Coldham et al., 2002).  Treatment adherence is a broad term that has been used 
across healthcare disciplines with varying definitions.  Types of treatment adherence are 
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medication adherence, appointment attendance, and following other recommendations 
made by clinicians.  Attendance at scheduled appointments and frequency of taking 
medications as they are prescribed are also commonly used domains to measure 
adherence.  However, even within the same domain, thresholds differ regarding what is 
considered to be adherent.  For example, attending the first scheduled appointment versus 
attending five consecutive appointments or taking prescribed medications a certain 
percentage of the time are different means for measuring the same adherence-related 
variable.  The problem with such diverse definitions for a construct is that the clinical 
implications because of meta-analyses are limited, as they are difficult to interpret (Nose, 
Barbui, Gray, & Tansella, 2003).   
The definition of medication compliance also varies throughout the literature.  
Coldham et al. (2002) defined medication adherence on a continuous measure as 
follows: Good adherence: rarely or never missed doses of medication, inadequate 
adherence: taking medication irregularly (skipped doses but never longer than a 
few weeks at a time in the 1-year time period), non-adherence: dropped out of the 
program before 1 year (without good reason), and/or took their medication 
erratically (ie: stopped for months at a time), or not at all. (Coldham et al., 2002, 
p. 287).   
Generally speaking, treatment adherence has been defined as “the extent to which 
a patient’s behavior (in terms of taking medication, following a diet, modifying habits, or 
attending clinics) coincides with medical or health advice” (McDonald, Garg, & Haynes, 
2002, p. 2868). 
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Service engagement has also been defined in many ways throughout the literature.  
The Center on Treatment Adherence and Self-Determination (2010) defined service 
engagement by emphasizing two crucial aspects of treatment: (a) consumers are included 
in their healthcare decisions along with providers and (b) service engagement includes 
other treatment-related consumer services, such as peer support, alternative therapies, and 
other nontraditional mental-health services.  Thinking about individuals’ engagement has 
expanded the construct of treatment adherence from a solely quantitative measure to 
qualitative domains, such as treatment satisfaction (Tetley, Jinks, Huband, & Howells, 
2011).  Treatment adherence is a necessary, but not defining, domain for an individual to 
become truly engaged in his or her services.  For purposes of this study, service 
disengagement refers to the number of missed mental-health appointments that had been 
scheduled in the previous 6 months.  Also the purpose of the current study, psychiatric 
appointment attendance and medication adherence, which are two indicators of service 
engagement, are the measured variables.  Although varying definitions of treatment 
adherence are in the literature, for the purposes of this study, the definition of service 
engagement is limited to psychiatric appointment attendance and medication adherence.  
The population included consists of people diagnosed with schizophrenia spectrum 
disorders.   
Medication adherence and appointment attendance have been researched in the 
psychiatric literature, as well as in general medical literature.  Several overarching 
theories about people’s behaviors in relation to their healthcare have been developed 
from the research in an attempt to explain the complicated problem of treatment 
nonadherence.   
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Theories of Nonadherence 
 The most prominent theories of health behavior include the health belief model, 
theory of reasoned action, protection motivation theory, and subjective expected utility 
theory (Ronis, 1992; Weinstein, 1993).  These four theories have many commonalities, 
including the assumption that people anticipating negative health outcomes will 
experience an increase in their motivation to engage in health-protective behaviors, their 
perception of the likelihood that the negative outcomes will occur increases their 
motivation, and peoples’ motivation to engage in health-protective behaviors increases as 
their expectation that their action will reduce their likelihood of being harmed increases 
(Weinstein, 1993).  A full review of these theories is beyond the scope of the current 
study. 
 Although widely adopted and well researched in the medical field, these models 
do not fully explain service disengagement and antipsychotic medication nonadherence, 
especially of people with schizophrenia spectrum disorders.  Furthermore, the existing 
models are underresearched in the mental-health-field, and they do not seem to 
comprehensively capture all domains that may impact a person’s healthcare decision-
making.  Some of the questions that remain unanswered by these health models are the 
importance of emotional experiences; the roles of self-esteem, social stigma, and 
empowerment; consumers’ beliefs of treatment effectiveness related to their past 
treatment experiences; complexities of actions that need to be taken; and other attributes 
of precautions aside from beliefs about effectiveness (eg., attitudes toward psychiatric 
treatment; Weinstein, 1993).  Several of these variables have not been addressed by 
traditional health behavior models. 
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 Although current behavioral-health theories have provided explanations for 
treatment gaps and some interventions have been effective in increasing treatment 
adherence, nonadherence remains problematic.  Possibly the existing interventions for 
increasing adherence are not widely used, or they do not comprehensively address the 
problem a given consumer has with being adherent to his or her treatment.  The amount 
of treatment nonadherence is such a widespread problem that researching the factors 
affecting existing interventions not being sufficiently adhered to is important, especially 
for people with psychotic disorders. 
Treatment Nonadherence Rates 
Researchers have found that about 25% of patients do not adhere to their medical 
treatment regimens (DiMatteo, 2004).  Patients with the highest rates of nonadherence are 
those with chronic diseases, as opposed to those with acute conditions (Sabaté, 2003).  
The population of the current study consists of people with schizophrenia spectrum 
disorders, which are often considered to be chronic conditions. 
About two thirds of people with schizophrenia spectrum disorders have been 
estimated to not adhere to their psychiatric treatment regimens.  Only about one third of 
people with schizophrenia are fully adherent to their medication regimens (Oehl et al., 
2000), which has been found to be related to poor overall treatment outcomes (Coldham 
et al., 2002).  Another third of them do not take their medication at all, and the remaining 
third are somewhat adherent, either by failing to take all of their medication doses or by 
reducing the dosage amounts without doctors’ orders (Oehl et al., 2000). 
People have been found to be at higher risk for medication nonadherence closer to 
the onset of their psychotic condition.  Mitchell and Selmes (2007) reported a 75% 
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discontinuation rate of psychotropic medication within 1 year of starting a new 
prescription, often without reporting such discontinuation to the prescribing physician. 
Other researchers have found about 40% of people stop taking their prescribed 
medication within the first year of the onset of their schizophrenia, and about 75% stop 
within the first 2 years (Coldham et al., 2002).   
A systematic review of 103 published studies was conducted to obtain an overall 
estimate of psychiatric treatment nonadherence, and the researchers found that almost 
26% of patients with schizophrenia spectrum disorders did not adhere to their medication 
regimens and did not attend scheduled appointments (Nose et al., 2003). Improvements in 
medication adherence rates have been found when clinicians are able to regularly monitor 
patients’ medications at attended mental-health appointments (Mitchell & Selmes, 2007).  
Unfortunately, attendance rates for mental-health appointments in general are also poor.   
Appointment attendance is a widely noted problem among psychiatric patients 
who are discharged from inpatient facilities.  Kruse, Rohland, and Wu (2002) found 18% 
of people discharged from a psychiatric hospital did not attend their follow-up outpatient 
appointments.  Researchers examined missed appointments among 342 outpatients 
diagnosed with Schizophrenia, Schizoaffective Disorder, or Delusional Disorder for a 
period of 2 years.  The researchers found 22.2% of the total appointments for this 
population were not attended (as cited in Kruse et al., 2002).  Agyapong, Rogers, 
MacHale, and Cotter (2010) found 44% of people who were seen by psychiatrists at a 
hospital emergency room did not attend their follow-up appointments at outpatient 
mental-health clinics.  Even higher rates of appointment nonadherence have been found 
in urban areas with people who have severe and persistent mental illness.  Compton, 
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Rudisch, Craw, Thompson, and Owens (2006) reviewed charts of people who were 
discharged from a community inpatient hospital and crisis stabilization unit who had 
follow-up appointments scheduled at either a community mental-health outpatient clinic 
or an intensive outpatient program in the area.  Their sample consisted of 221 patients, 64 
% of whom did not attend their follow-up appointments (Compton et al., 2006).  
Lapses or delays in interventions seem to be problematic for outpatient 
appointment attendance rates. Killaspy, Banerjee, King, and Lloyd (2000) found patients 
are significantly more likely to continue to attend outpatient mental-health appointments 
6 months after their first visit if they attended their first follow-up appointment.  They 
concluded that a single missed appointment can predict service disengagement from an 
outpatient mental-health-clinic (Killaspy et al., 2000).  These findings highlight the 
importance of continued contact with patients and of discussing with them the reasons for 
their missed appointments. 
Although the research outcomes on rates of treatment nonadherence vary, clearly 
that at least one quarter to three quarters of people with schizophrenia neither take their 
medication as prescribed nor attend their scheduled mental-health appointments.  Given 
this vast number of people with schizophrenia spectrum disorders who do not adhere to 
their treatment regimens, poor prognoses for them can be expected, as well as negative 
effects on their environment, on the lives of people who care for the mentally ill, on 
results of treatment efficacy research, and on the healthcare system in general. 
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Consequences of Nonadherence 
Consequences of nonadherence to mental-health treatment for people with 
schizophrenia include psychiatric symptom exacerbation and readmission to inpatient 
psychiatric hospitalizations, as well as becoming homeless, occasionally violent toward 
other people, and suicidal (Kreyenbuhl, Nossell, & Dixon, 2009).  When people with 
schizophrenia spectrum disorders are not taking their prescribed medication, they have 
been found to have higher hospitalization rates, poorer outcomes, and increased relapse 
of psychotic episodes (Coldham et al., 2002).  Additional factors that have been found to 
be affected by nonadherence include reductions in the possible benefits of treatment, 
biased assessment of treatment efficacy, and overall worse prognoses (McDonald & 
Haynes, 2002).  
Medical-possession-ratios (MPR) are a measure of medication treatment 
adherence, with a perfect ratio being equivalent to 100% medication adherence as 
prescribed.  Specifically with regards to inpatient hospitalization rates, veterans with 
schizophrenia who have close-to-perfect MPRs have been found to have the lowest 
inpatient hospital admission rates.  Furthermore, as the patients’ MPRs declined, 
hospitalization significantly increased, and the veterans also spent more days spent in the 
hospital during their inpatient admissions.  Further research has found that patients who 
follow their psychiatric medication regimens less than 80% of the time were almost 2 ½ 
times more likely to be hospitalized than those with higher levels of adherence 
(Valenstein et al., 2002). 
Hospitalization rates for medical and psychiatric reasons rise significantly for 
consumers who are nonadherent.  Consumers who are partially adherent to their 
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antipsychotic medication regimens were found to be 2 ½ times more likely to be 
hospitalized for psychiatric reasons than those who are adherent.  Moreover, medical 
hospitalization rates increase with antipsychotic treatment nonadherence.  Consumers 
with schizophrenia have been found to have worse overall physical health than people 
with depression or no mental illness.  Consumers who are nonadherent, partially 
adherent, or take their medications more than prescribed are more likely to be 
hospitalized for medical reasons.  People with schizophrenia who are nonadherent to their 
treatment are likely more symptomatic, which makes them less capable of attending to 
their medical and physical needs, including attending medical appointments.  Other 
behaviors that promote poor health can be assumed to occur more frequently in those 
who are less adherent to mental-health treatment and are therefore more symptomatic.  
Healthcare costs increase in association with these issues related to mental-health 
treatment nonadherence.  Conversely, healthcare costs are not significantly increased 
when consumers with schizophrenia adhere to their mental-health treatment, and the 
treatments are cost effective (Dolder et al., 2004). 
People who are nonadherent within the first year of the onset of their 
schizophrenia have been found to have higher relapse rates and increased frequency and 
severity of positive psychotic symptoms (eg., hallucination, delusions, disorganized 
speech and behavior) than medication-adherent individuals with schizophrenia (Coldham 
et al., 2002).  Discontinuation of psychiatric medications without attending appointments 
does not allow for the patients to receive medical advice about their options, which 
makes them more likely to make an uninformed decision to discontinue their medications 
(Mitchell & Selmes, 2007).  Attending regular mental-health appointments seems 
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essential for adherence to prescribed medications and to avoid the negative consequences 
that are associated with treatment nonadherence.  
Significant evidence suggests that missed mental-health appointments are often an 
indication that the patient’s psychiatric health is deteriorating and sometimes that their 
overall quality of life is declining (Mitchell & Selmes, 2007).  Killaspy et al. (2007) 
conducted a study of 365 mental-healthcare out-patients, in which they found patients 
who missed their appointments after their initial visit were more functionally impaired 
than patients who attended appointments.  Specifically, the patients who did not attend 
appointments had decreased social functioning, more severe psychiatric symptoms, and 
significantly increased chances of having been admitted to a psychiatric hospital in the 
previous year than did those who attended their appointments (Killaspy et al., 2000).   
Consequences of appointment nonadherence sometimes influence clinicians’ 
attitudes, which can negatively affect the care patients receive.  In studies of the effects 
that patients’ missed appointments can have on healthcare providers have revealed higher 
levels of frustration, negative attitudes toward patients (Husain-Gambles, Neal, & 
Dempsey, 2004), decreased empathy for the patients, and lower quality of 
communication between the patient and the provider (Pesata, Pallija, & Webb, 1999).  
Furthermore, missed appointments create financial losses for outpatient mental-health 
clinics and can create a more challenging situation for quality services to be provided 
(Gallucci, Swartz, & Hackerman, 2005).  
The negative impact that treatment nonadherence has on people with 
schizophrenia is well researched, as are factors that correlate with nonadherence.   
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Correlates of Nonadherence 
Treatment nonadherence has been researched in populations suffering from 
schizophrenia spectrum disorders, and results have revealed several correlates and 
predictor variables.  Many factors have been theoretically linked to treatment 
nonadherence among individuals with schizophrenia, such as psychosocial factors, 
culturally influenced attitudes toward psychiatric treatment, access to care, and 
biologically determined ethnic differences in medication and treatment response rates.   
The bulk of research on treatment nonadherence has looked at psychosocial 
factors, such as patient demographics, and illness variables in the prediction of treatment 
nonadherence.  Researchers have found factors correlated with nonadherence, including 
impaired insight, presence of positive symptoms, younger age, male gender, 
unemployment, poor social functioning, lack of family involvement, premorbid substance 
abuse, poor premorbid functioning, and low levels of quality-of-life indicators (Coldham 
et al., 2002; Nose et al., 2003).   
Additional patient-related factors of nonadherence include the patients’ beliefs 
about illness and their knowledge of medication, which is especially true for people 
prescribed antipsychotic medications.  Patients’ misunderstanding of their prescription 
instructions, misunderstanding of why they are taking medication, general lack of 
understanding of their illness, feelings of not being involved in treatment decisions, and 
inability to give informed consent for treatment because of lack of insight are all patient-
related factors related to treatment nonadherence.  Furthermore, misconception of the 
severity of the illness, dysfunctional attitudes regarding health, inability to communicate 
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with treatment providers, and negative attitudes about treatment in general are variables 
that have been found to be correlated with nonadherence (Mitchell & Selmes, 2007).   
Certain personality traits and social factors have also been identified as predictors 
of nonadherence.  Specifically, low levels of neuroticism and high levels of agreeableness 
are predictors of poor service engagement (Kreyenbuhl et al., 2009).  The researchers 
who found these results explained that agreeableness is a personality trait that makes 
people more susceptible to peer pressure to avoid stigmatization associated with 
receiving mental-health treatment.  Socially, poor service engagement related to avoiding 
stigmatization is likely more problematic in people who are early in their experience with 
psychosis because of their desire to be accepted by peers and fear of being ostracized 
because of the stigma associated with psychiatric treatment.  Consumers who were being 
made more aware of the possible social stigma accompanying mental-healthcare were 
found to have higher service disengagement rates (Kreyenbuhl et al., 2009).    People 
who have recently received a diagnosis of a schizophrenia spectrum disorder may be 
more unaware of treatment benefits and are more likely to have increased denial 
regarding their illness; therefore, psychoeducation is critical.  Identification of high rates 
of mental-health treatment nonadherence allows for a more comprehensive understanding 
of how widespread and pervasive this problem is for consumers and their families. 
Additional environmental and social issues, such as lack of access to 
transportation, forgetting appointments, moving away from their provider’s location, and 
not having enough time to attend appointments, have also been cited as reasons for 
nonadherence (Kreyenbuhl et al., 2009). 
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Reports of mental-health consumers have provided researchers with additional 
patient-related factors of nonadherence.  Patients most commonly reported the desire to 
solve their own problems as one of the reasons for their treatment nonadherence.  Other 
explanations provided by consumers included being dissatisfied with the treatment they 
were receiving, feeling their illness had improved, believing treatment would not help 
them, feeling that they were too sick to be treated, feeling a loss of control because of the 
effects and side effects of the medication, and wanting to feel independent (Kreyenbuhl et 
al., 2009).  Additional correlates of treatment nonadherence identified by consumers were 
related to treatment constraints of non-recovery-oriented interventions.  Consumers 
reported feeling that the treatment providers were not sympathetic, not listening to them, 
and not allowing them to participate in the decision-making process and expressed 
general dissatisfaction with the services being provided to them (Kreyenbuhl et al., 
2009).  Poor service engagement has been found to be associated with a lack of 
psychoeducation regarding consumer rights, which is likely the result of misperceptions 
of mental-healthcare (Lecomte et al., 2008).   
Physician-related correlates of nonadherence, such as mistrust of healthcare 
professionals and poor therapeutic alliance, have also been identified by researchers.  
Kreyenbuhl, Nossel, and Dixon (2009) identified a childhood history of being the victim 
of physical or sexual abuse as the strongest predictor of service disengagement for people 
with schizophrenia.  Having a sexual-abuse history has been suggested to negatively 
affect treatment adherence because it creates mistrust of authority figures, which would 
include mental-health professionals.  The second strongest predictor of nonadherence 
found in this study was determined to be poor therapeutic alliance with the therapist.  
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People with histories of childhood physical abuse were found to have poorer therapeutic 
alliances with their mental-health service providers than were people without such 
histories (Kreyenbuhl et al., 2009).     
Additional physician-related factors of nonadherence include involuntary or 
mandated treatment.  Swartz, Swanson, and Hannon (2003) found that people diagnosed 
with schizophrenia and the clinicians who treat them generally have differing views about 
treatment options, such as involuntary hospitalization.  More than three quarters of the 
clinicians surveyed believed that mandated treatment makes the consumers more likely to 
remain in treatment.  Conversely, more than one third of the consumers with 
schizophrenia reported fear of involuntary commitments and being coerced into treatment 
as barriers to seeking mental-health treatment.  The authors referred to this phenomenon 
as “mandated-treatment-related barriers to care” (Swartz et al., 2003, p. 470).  More 
specifically, they found that people with a history of involuntary hospitalizations, court-
mandated treatment, and having representatives as their payees are more reluctant to seek 
outpatient treatment out of fear of coercion than are their counterparts who do not have 
such histories.  Furthermore, recent inpatient hospitalizations and recent warnings about 
the potential consequences associated with treatment nonadherence were found to be 
significantly correlated with mandated-treatment-related barriers to care.  The authors 
acknowledged that people with a history of involuntary commitments may have been 
more reluctant to seek treatment in the first place, were more severely ill, and were more 
mistrustful of treatment.  However, they concluded that coercive treatment tactics are a 
deterrent to voluntarily seeking treatment (Swartz et al., 2003). 
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Mitchell and Selmes (2007) distinguished between intentional and unintentional 
nonadherence.  Unintentional nonadherence would include such obstacles as forgetting to 
take a dose of medication.  The researchers found that predictors of intentional 
nonadherence include feeling less ill, the desire to manage the illness independently, 
mistrust of clinicians, and lack of information from the treating clinicians.  They referred 
to the utility theory of health beliefs to explain that consumers base their decisions to 
intentionally nonadhere by forming a balance between their reasons for and against 
adhering to their treatment (Mitchell & Selmes, 2007).   
Biologically determined differences in medication and treatment response rates 
constitute another category of correlates of nonadherence.  Side effects of antipsychotic 
medication have been identified as an area of concern that is associated with 
nonadherence.  Specifically, weight gain and sexual dysfunction are two of the most 
significant side effects reported to affect adherence rates.  Fakhoury et al. (1999) found 
subjective distress and medication nonadherence to be associated with weight gain 
caused by medication.  Furthermore, weight gain associated with antipsychotic 
medication was the most frequently reported side effect to be extremely distressing (more 
than 70% of consumers prescribed antipsychotics; Fakhoury, 1999).  Sexual dysfunction 
has also been linked to significant levels of subjective distress and lower ratings on 
quality-of-life measures (Rosenberg, Bleiberg, Koscis, & Gross, C., 2003). 
The literature has not found any consistent psychosocial predictors, but some 
research has noted some association between younger age, male gender, ethnic minority 
background, and low social functioning.  However, even the correlations of these 
variables and treatment nonadherence have not been consistently reported in all studies 
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that have investigated them (Kreyenbuhl et al., 2009; O’Brien, Fahmy, & Swaran, 2009; 
Vermeire, Hearnshaw, Van Royen, 2001).  Researchers have looked at system variables 
related to treatment adherence, such as continuity of care and, only more recently, 
patients’ perceptions of the services they receive.  Psychosocial factors of the 
pathological symptoms of schizophrenia such as, lack of family support, social isolation, 
and homelessness, can have a damaging effect on treatment adherence, (Dolder et al., 
2004).   
Correlates of treatment Nonadherence, including variables in domains of 
physician-related, environmental, social, patient-related, and biological differences have 
been extensively researched.  However, no consistent results have been found with regard 
to static illness-related patient-related factors; therefore, research needs to refocus on 
dynamic patient-related variables, including, PDM, empowerment, perceptions of 
clinicians’ cultural competence, attitudes toward treatment and psychiatric treatment, and 
other recovery-related constructs.  Although consumers’ perceptions of provider variables 
have been highlighted in the literature as important for treatment engagement, research 
into these correlates has just begun.  
Given the wide scope of variables that have been found to be correlated with 
treatment nonadherence, researchers and clinicians have attempted to ameliorate this 
problem by developing interventions aimed at increasing adherence. 
Effective Interventions for Treatment Adherence 
Medication nonadherence has been identified as the most preventable cause of 
psychiatric hospitalization, acute episode relapse, and overall poor outcomes; however, it 
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remains one of the largest obstacles to successful treatment of people with schizophrenia 
(Coldham et al. 2002).   
In a systematic review of research on treatment nonadherence, many interventions 
for increasing treatment adherence in community psychiatric services were determined to 
be effective (Nose et al., 2003).  The authors noted that  the effective interventions 
included using letters and phone calls to remind consumers of their scheduled 
appointments, psychotherapeutic and family interventions (cognitive and psychodynamic 
approaches), education about treatment and medication, scheduling follow-up 
appointments, and implementing treatment adherence contracts prior to hospital 
discharge.  Overall, these interventions were found to increase attendance at scheduled 
mental-health appointments and adherence to psychotropic medication regimens by more 
than 50%, 6 months following the intervention.  The long-term benefit of these 
interventions was assessed for effectiveness in only a minority of the studies included in 
the meta-analysis.  The available evidence suggests that with an increase of time 
following the interventions, the less effective they become (Nose et al., 2003); therefore, 
longer lasting interventions are needed to increase adherence rates.   
Rossotto, Wirshing, and Liberman (2004) conducted a study of a community 
reentry model to assess its efficacy for increasing outpatient treatment adherence for 
people diagnosed with schizophrenia after being released from inpatient hospitalization.  
This model involves four categories of educational components: scheduling and attending 
appointments, medication management, relapse prevention, and mental-illness symptom 
identification.  The consumers who received the community reintegration intervention 
had higher rates of outpatient treatment adherence (75%) and lower rates of 
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rehospitalization (0%), as compared to the group who received only psychoeducation, 
who had  a  33% treatment attendance and 50% rehospitalization rate within 12 months 
(Rossotto et al., 2004).  Although these interventions have shown some improvement in 
treatment nonadherence, they do not seem to change individuals’ health-related behaviors 
in the long run.  
Correlates and consequences of nonadherence have been identified and theories 
and interventions have been developed, and yet adherence continues to be one of the 
greatest barriers to effective treatment for these individuals. The health belief theories do 
not provide explanations for patient-related factors that are important for understanding 
the individual experience (e.g. emotional experiences, self-esteem, social stigma, 
empowerment, past treatment experiences, complexities of practical issues of adhering to 
treatment, and attitudes toward psychiatric treatment).  These variables are generally not 
taken into consideration when examining nonadherence for people with schizophrenia.  
These variables, however, are related to person-centered care and incorporated into 
treatment aligned with recovery-oriented care. The recovery paradigm provides a 
research framework for treatment adherence in which variables that are important to 
mental-health consumers can be identified and examined. 
   The recovery principles afford researchers an opportunity to empirically examine 
consumer-generated variables with regard to their association with treatment adherence.  
Recovery Movement 
The recovery movement presents a shift in mental-health service provision from a 
medical model that focuses on medical care and symptom elimination and management 
to a model that is more holistic in its view of individuals with mental-health problems, is 
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person centered, and is focused on wellness.  This approach emphasizes collaborative 
decision-making between the consumer and the provider, empowerment of the individual, 
involvement of community, and family and peer support.  The Substance Abuse and 
Mental-health Services Administration (SAMHSA, 2012) released a press statement 
announcing the newest version of its evolving definition of recovery: “A process of 
change through which individuals improve their health and wellness, live a self-directed 
life, and strive to reach their full potential.” SAMHSA has published 10 “Guiding 
Principles of Recovery” to further define the construct of recovery and the associated 
values.  These principles have been identified as follows:  
Recovery emerges from hope, is person-driven, occurs via many pathways, is 
holistic, is supported by peers and allies, is supported through relationship and 
social networks, is culturally-based and influenced, is supported by addressing 
trauma, involves individual, family, and community strengths and responsibility, 
and is based on respect (SAMHSA, 2012).   
Resnick, Fontana, Lehman, and Rosenheck (2005) developed empirically derived 
conceptualizations of recovery that have revealed four domains that encompass the 
definition of recovery-oriented treatment.  The four domains are empowerment, hope and 
optimism, knowledge, and life satisfaction.  Empowerment, in the context of mental-
health treatment, was found to be the strongest indicator of recovery-oriented treatment 
and is defined as feeling the power to take responsibility for one’s treatment and feeling 
that one’s treatment providers are helping one to achieve personally meaningful goals.  
Hope and optimism include hope for the future, hope for accomplishing goals, and hope 
for being around supportive people who foster hope.  Knowledge refers to persons’ 
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perceptions of their knowledge about their mental illness and the confidence they have in 
navigating within the mental-health system.  Life satisfaction involves feeling satisfied in 
the areas of life including family, friendships, housing arrangements, safety, and sense of 
community (relationships with others and safe housing).  Family psychoeducation is 
important for communication between the consumer and his or her family (Resnick et al., 
2005).  Aspects of this recovery conceptualization, such as empowerment, life 
satisfaction, and knowledge, have been applied in interventions that are aimed at 
involving patients in important decisions and at learning skills needed to achieve their 
individualized goals.  
The community reentry model of treatment was developed to bridge the gap 
between inpatient and outpatient services for people with schizophrenia.  The model 
involves daily groups while the consumers are in the hospital and weekly groups once 
they are outpatients.  The groups are designed to teach the patients communication and 
decision-making skills by using motivational interviewing, role play, problem solving, 
and involvement with community assignments.  The components of the program align 
with the recovery paradigm by involving the patients in their treatment and life decisions 
and learning the skills needed to achieve their goals.  The treatment is conducted through 
psychoeducation for consumers, encouraging the incorporation of consumers’ 
experiences in the topic being discussed in group, and applying the skills they learn to 
their individual life situations in outpatient treatment.  The results of using the 
community reentry model have been reduced rehospitalization rates and increased rates 
of outpatient treatment adherence (Rossotto et al., 2004). 
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The recovery paradigm helps to reconceptualize the focus of treatment adherence 
because it shifts treatment focus to factors that have been found to matter to consumers, 
such as their attitudes, beliefs, and perceptions of mental-health providers and their 
illness.  
Participatory Decision-making (PDM) 
PDM was originally defined by Kaplan, Gandek, Greenfield, Rogers, & Ware 
(1995) as patients’ perceptions of their physicians’ tendency to include them in the 
decision-making process.  It was measured by a 5-point Likert scale consisting of three 
questions:  
(1) If there were a choice between treatments, how often would this doctor ask 
you to help make the decision? (2) How often does this doctor give you some 
control over your treatment? And (3) How often does this doctor ask you to 
take some of the responsibility for your treatment? 
(Cooper-Patrick et al., 2009, p. 585).  The definition of PDM has evolved to 
involve the consumer as an equal partner in the decision-making process, which includes 
being considered a self-expert, given his or her lived experiences and knowledge 
(Cooper-Patrick et al., 2009).  For example, shared decision-making between 
psychiatrists and consumers of mental-healthcare allows the consumers to share their 
expertise about how the medications affect them and the advantages and disadvantages 
the medications provide for their recovery process. The providers are considered experts 
about the research and clinical experience, and the consumers are viewed as experts on 
their subjective experiences and preferences.  The job of the providers is to assist in 
proper use of medications and other coping strategies that facilitate management of the 
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illness, rather than to ensure the patient complies with the medication regimen that is 
prescribed for them.  Shared decision-making involves using language that facilitates 
recovery, such as “education, working alliance, individual experience, informed choice, 
collaborative experiments, and self-management of illness” (Deegan & Drake, 2006, 
p.1638).   
PDM requires that psychiatrists involve the patient in a shared decision-making 
process.  The clinician’s communication style is important for the consumer’s satisfaction 
with his or her treatment.  Physicians communicating more effectively with consumers 
during follow-up visits were found to be predictive of higher rates of medication 
adherence than for physicians who did not communicate effectively with the consumers.  
More effective communication involved a collaborative style and enhancement of the 
consumer’s education regarding his or her illness and the medication (Mitchell & Selmes, 
2007).  
An abundance of evidence supports the association between PDM and improved 
medical treatment outcomes (Epstein, Alper, & Quill, 2004).  Therefore, more research 
on PDM and how it may be related to mental-health treatment adherence is warranted. 
Loh, Leonhart, Wills, Simon, and Hater (2007) studied PDM in relation to general 
practitioners treating patients with depression.  The researchers reported one of their key 
findings to be an increase in treatment adherence that was indirectly related to patients’ 
participation in medical decisions.  Their interpretation of the results is based on 
adherence having a significantly strong influence on the patients’ clinical outcome and 
the strong influence of patient participation in decision-making on treatment adherence 
(Loh et al., 2007). These results provide support for improved clinical outcomes for 
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physicians treating mental-health consumers when the consumers are involved in the 
decision-making.  Furthermore, the researchers determined that “sixty percent of the 
variance in clinical outcome was attributable to patient adherence” (Loh et al., 2007, p. 
69); therefore, treatment adherence may act as a moderator for influencing symptom 
reduction.  This finding provides more support for the need to find ways to increase 
treatment adherence.  Further research is needed to determine if these results can be 
replicated with a patient population with psychotic disorders. 
Loh et al. (2007) published further on the topic of PDM in primary care of 
patients with depression.  They found moderately improved treatment adherence in their 
group who received the PDM intervention.  The intervention included decision aids and 
informational leaflets that were given to the patients and physicians.  The decision aids 
were used during consultation with the physician, and they consisted of details about 
symptoms, diagnosis, treatment options,  costs and benefits of treatment options, and 
support for patients’ values.  The leaflets added information about health beliefs, coping 
strategies, family involvement, and tips to foster PDM.  The researchers concluded that 
PDM strategies promote medication adherence in primary care settings.  Their findings 
were consistent with Loh et al.’s (2007) previous conclusions that PDM interventions can 
be feasibly implemented in primary-care settings, specifically because including patients 
in the decision-making process does not require longer periods of time for treatment 
implementation (Loh et al., 2007).  The leaflets given to the intervention group contained 
information that is central to patient-centered care and recovery-oriented care provision, 
such as addressing beliefs of the consumers, involving supportive people in treatment, 
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and collaborative decision-making between the consumers and their mental-health 
treatment providers. 
In a survey of almost 200 psychiatrists, more than half reported routinely 
including their patients with schizophrenia in the decision-making process (Hamann et 
al., 2009).  Patient factors and decision types were identified in relation to whether a 
PDM was used.  Patients who were determined to be insightful, educated about their 
illness, and expressive of their desire to be involved in decision-making were more 
commonly chosen for such an approach.  Additionally, patients who had a history of 
noncompliance, or were somewhat resistant to receiving psychiatric treatment, were 
identified by the psychiatrists as possible candidates for participating in their psychiatric 
treatment decisions as an attempt to improve their attitudes toward treatment and 
likelihood of accepting antipsychotic medication. The types of decisions that seem to 
necessitate a psychiatrist’s use of PDM are those related to psychosocial aspects of 
treatment (Hamann et al., 2009).  Certain medical aspects of treatment, such as 
medication dosage and hospitalization decisions, have been found to be the most 
frequently disagreed upon topics of decision making between psychiatrists and patients.  
However, these decisions also lend themselves well to involving both the expert 
knowledge of the physician and the experiential knowledge of the consumer because of 
the possible benefits of positive attitudinal changes for the consumers toward their 
treatment.  Specifically, medical decisions that were made by the physicians using a 
paternalistic approach were more likely to be overturned by the patient once their acute 
episodes passed, likely resulting in an overall poor prognosis for these patients (Hamann 
et al., 2009).  
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Hamann et al. (2009) identified several barriers to implementing shared decision-
making.  Patients who are considered to have impaired decisional capacities have been 
less likely to be included in PDM by psychiatrists, as professionals have questioned these 
consumers’ competencies to participate in the process.  Furthermore, some decisions 
have medical and legal implications that are in the domain of the expert physician, such 
as hospitalization, legal guardianship, and using antipsychotic medication, and thus are 
considered appropriate to be handled only by the professional once PDM has failed. 
Other medical decisions lend themselves to be handled with both the experiential 
knowledge of the patient and the expert knowledge of the psychiatrist.  These decisions 
include antipsychotic agent choice, discharge planning, and the use of supplemental 
antidepressant medications.  With patient characteristics and types of decisions taken into 
consideration, psychiatrists generally expressed a preference to involve patients in 
treatment decisions, as much as clinically and logistically appropriate (Hamann et al., 
2009).  Finding ways to overcome the barriers to PDM is needed in research to improve 
treatment adherence and overall mental-healthcare outcomes.  The recovery movement is 
aimed at involving mental-healthcare consumers in their own treatment; therefore, 
interventions that are recovery-oriented should produce these more favorable outcomes. 
Interventions aimed to increase PDM in treating consumers with schizophrenia 
have been found to be associated with significant positive treatment changes, such as 
increases in the uptake of consumers’ psychoeducation, increases in their perceived 
involvement in treatment decisions, and better overall  health outcomes related to 
schizophrenia (Hamann et al., 2006; Hamann et al., 2009).  The PDM intervention 
examined in a randomized controlled trial by Hamann et al. (2006) consisted of 
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informing patients about their treatment options and teaching planning talk to them to 
facilitate discussions with their physicians about their treatment decisions.  The nurses 
indicated that most of the patients they encountered were capable of PDM, and the 
psychiatrists rated 51% of the consumers as able to make reasonable decisions.  Although 
the psychiatrists did not rate the intervention group as having significant changes in 
psychopathology, in Working Alliance Inventory scores, and in estimated adherence rates 
compared to the control group; the psychiatrists did report overall greater satisfaction 
with what the intervention group had achieved during their hospitalizations.  The 
consumers who received the intervention perceived a more positive overall outcome and 
significantly greater involvement in their medical decisions.  Furthermore, the 
intervention group demonstrated significantly more knowledge about their illness upon 
discharge, more involvement in psychoeducation and socio therapeutic interventions, and 
overall more positive attitudes toward medication and toward their mental-health 
treatment in general.  According to the psychiatrists and nurses, the intervention was 
feasible in common practice because of the timeliness of the intervention and the ability 
of most consumers to participate in decision-making (Hamann et al., 2006).   
Recovery-oriented treatment provision envisions shared decision-making between 
the consumer and the provider of treatment.  Such an approach denotes that both parties 
have expertise and knowledge that should be considered when making any treatment 
decision.  In the recovery model, shared decision-making between the consumer and the 
provider is considered to be the most effective treatment approach (Deegan & Drake, 
2006).    
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PDM is an essential aspect of recovery-oriented treatment; however, enhancing 
empowerment in consumers is another principle of recovery that might be necessary in 
order for consumers to feel confident in involving themselves in the decision-making 
process. 
Empowerment 
Empowerment involves having a sense of control over one’s life and having 
control over decisions. Examples of decisions include whether to participate in treatment, 
what type of treatment to participate in, and extending control over treatment to other 
aspects of life (Bellack, 2006).  Empowerment has been defined in many ways in the 
mental-health field.  Dickerson (1998) developed a comprehensive definition of the 
construct consisting of three components of empowerment.  The first component is 
having a sense of personal competence, which refers to the ability of persons demonstrate 
having a positive attitude about themselves (positive self-esteem), being able to accept 
that they have a mental-health disability (accepts psychiatric disability), and feeling a 
sense of personal control over situations in their lives (internal locus of control).  Having 
positive self-esteem comes from feedback from others, as well as from self-appraisal and 
building self-worth.  Self-esteem has been agreed by most researchers to be a core 
component of empowerment.  Accepting one’s psychiatric disability involves awareness 
that fosters personal recovery and protects against self-stigma.  Having an internal locus 
of control allows for people to perceive themselves as active participants in what happens 
in their lives, so that rewards and punishments are a result of their behavior, rather than 
luck or other external forces (Dickerson, 1998).  The second component included in the 
definition of the construct of empowerment is self-determination.  This component 
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concerns the consumers’ amount of participation in decisions that affect their lives, 
including determining the course of their mental-health treatment and whether or not they 
participate in it.  The third component of empowerment refers to consumers’ ability to 
value one another, to identify with their peers, and to validate each other.  This peer 
support is considered important because it leads to social activism for improving 
consumer treatment for the group as a whole (Dickerson, 1998). 
Better mental-health outcomes have been found to be associated with people who 
have a sense of personal power over decisions in their lives.  Specifically, interventions 
that promote empowerment in people with serious mental illness by providers adopting 
an attitude of recovery, working collaboratively with the consumers, and improving their 
relationships with consumers have been shown to facilitate goal attainment in mental-
health treatment (Corrigan, 2002).   
Research on interventions that are aimed at fostering empowerment has produced 
promising results.  More significant decreases in positive symptomatology have been 
found in individuals with schizophrenia who received treatment that was aimed at 
fostering empowerment when compared to participants who received non empowerment-
focused treatment (Lecomte et al., 1999).  The empowerment-focused intervention 
included activities aimed at developing coping skills, increasing the ability to set goals, 
and improving self-esteem, self-worth, self-determination, and competence.  The 
researchers concluded that the decrease in the participants’ positive symptoms stemmed 
from the empowering effect of the intervention.  The researchers suggested the 
empowering intervention could be used to enhance and promote a person’s recovery 
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process (Lecomte et al., 1999). Empowerment is directly involved in the recovery model 
and patient-centered care.   
Treatment programs that foster empowerment have many common characteristics, 
all of which promote person-centered care.  These characteristics include having 
consumers play a large role in the service process; allowing consumers to make personal 
choices about their participation in the services provided; having staff focus on the 
strengths of the consumers rather than on their illnesses; encouraging strong collaboration 
between staff and consumers in an egalitarian manner; encouraging consumers to 
participate in meaningful life activities, such as employment; and providing vocational 
training and other life skills training to the consumers (Dickerson, 1998).     
Empowering individuals with schizophrenia to be involved in their treatment is 
undoubtedly important for their overall success.  Empower individuals who have negative 
attitudes toward treatment becomes difficult.  Patients’ attitudes have been researched, 
and they are theoretically linked to the recovery movement. 
Attitudes Toward Treatment 
 Consumers’ negative attitudes toward mental-health treatment and general 
medical treatment are problematic for adherence.  Consumers with more positive 
attitudes toward treatment are more likely to attend follow-up appointments and report 
more satisfaction with their medication after first use (Mitchell & Selmes, 2007). 
Nonadherence to antipsychotic medication in people with a schizophrenia 
spectrum disorder has been found to be significantly affected by their attitudes toward 
receiving treatment (Day, Lopez Gaston, Furlong, Mural, & Copello, 2005).  Patients’ 
attitudes toward receiving antipsychotic medication have been found to be related to 
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various factors, including the patients’ relationships with the prescribing physician, their 
level of insight to their illness, and the quality of their experience upon admission to 
psychiatric treatment facilities.  Of the factors that influence patients’ attitudes toward 
treatment, the relationship quality between the patient and the physician was found to be 
the most influential variable affecting medication adherence (Day et al., 2005).  The 
quality of the relationship between the patient and the physician is a factor that is 
considered to be included in the principles of the recovery paradigm.  
Side effects of antipsychotic medications can also have a significant negative 
effect on patients’ adherence levels.  Specifically, patients with schizophrenia who were 
currently experiencing side effects reported being more doubtful that the medication 
would have a positive effect, being less likely to recommend a family member to take 
these medications if they needed medication, and having more negative attitudes toward 
psychiatric medications in general.  Furthermore, extrapyramidal side effects and sexual 
dysfunction side effects were found to have the strongest relationship with negative 
attitudes toward psychiatric treatment, resulting in later nonadherence.  Sedation and 
vegetative side effects had the least negative effect.  Fortunately, patients with a history 
of experiencing negative side effects were found to have improved attitudes toward 
psychiatric treatment if their previous side effects had been alleviated (Lambert et al., 
2004).  These results highlight the importance of clinicians inquiring about patients’ 
attitudes toward psychiatric treatment and using such information to make their treatment 
more person centered.  For example, involving the patient in collaborating with the 
prescribing physician to find medications with fewer undesirable side effects can increase 
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treatment adherence and improve the relationship between the provider and the 
consumer. 
Patients’ attitudes toward treatment are important because positive attitudes might 
lead the patients to agree with the rationale, trust the treatment providers, and adhere to 
the treatment.  Patients’ attitudes are influenced by how competent they perceive their 
treatment and the providers of their treatment to be.  Providers’ cultural competence and 
providing culturally competent treatment are growing areas of research.  In relation to the 
recovery movement, how competent the mental-healthcare consumers’ perceptions of the 
competency of thier treatment providers is influenced by how well they believe they are 
understood as individuals by their providers.  
Conclusion  
Interventions that have been aimed at increasing treatment adherence in people 
with schizophrenia spectrum disorders have fallen short of eradicating the problem of 
nonadherence.  The existing interventions likely do not fully address the whole person 
and the multiple reasons people do not consistently adhere to treatment.  Research has 
shown that fully involving the consumer in their individualized care and helping them to 
live lives that are meaningful are crucial to engaging consumers in the treatment process.  
This type of patient-centered care is the premise for the recovery movement.  Recovery-
oriented treatment is aimed at addressing individualized aspects of treatment by centering 
treatment on the consumers and what is important to them.  Empowerment, PDM, 
attitudes toward treatment, and cultural competence of treatment providers are critical 
aspects of recovery-oriented treatment.  Enhancing mental-health treatment by focusing 
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on these aspects of recovery-oriented care may serve to make mental-healthcare seem 
more appealing to consumers, thereby increasing treatment adherence. 
 The recovery movement changed the idea of how to provide treatment by 
considering the whole person in the process.  Many researchers have explored variables 
they hypothesized to be related to treatment nonadherence in people with schizophrenia.  
The variables that have been researched cover a broad range of categories, including 
those related to environmental factors, provider factors, and, most prominently, 
sociodemographic and illness-related patient factors.  However, these patient-related 
factors found to be correlated with nonadherence are static or largely unchangeable 
factors, such as gender, age and diagnosis, and the results of studies looking at these 
factors have been mostly inconsistent. The present study examines fluid or dynamic 
patient-related variables that are amenable to being addressed and improved if treatment 
were more patient centered and aligned with the recovery movement. 
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Chapter 2: Hypotheses 
Research on recovery-oriented principles has contributed to the understanding of 
how this framework of mental-health treatment provision can contribute to improving the 
lives of individuals with serious mental illnesses.  However, whether recovery-oriented 
treatment provision makes treatment adherence more desirable to consumers remains 
unclear. The research question addressed in this study investigated the relationship 
between recovery-oriented treatment principles and treatment adherence in consumers 
with a schizophrenia spectrum disorder. It is hypothesized that consumers with a 
schizophrenia spectrum disorder will attend more mental-health appointments and more 
often take their prescribed psychotropic medication more often if they perceive their 
services to be recovery-oriented, if they perceive their treatment to involve empowerment 
and participatory decision-making, if they perceive their providers as skilled and 
culturally competent, and if they have positive attitudes toward receiving medical and 
psychiatric treatment.  The following two hypotheses for the current study were derived 
from this framework: 
Higher self-reported participatory decision-making, higher levels of empowerment, 
higher levels of recovery attitudes, higher levels of perceived provider skills and cultural 
competence, and positive attitudes towards treatment will predict attendance at outpatient 
psychiatric appointments.   
Higher self-reported participatory decision-making, higher levels of empowerment, 
higher levels of recovery attitudes, higher levels of perceived provider skills and cultural 
competence, and positive attitudes towards treatment will predict psychotropic 
medication adherence. 
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Chapter 3: Methods 
The purpose of this study is to examine variables that reflect a person-centered 
approach to psychological care that are hypothesized to be predictive of higher levels of 
treatment adherence for people with a schizophrenia spectrum disorder.  The recovery 
movement in mental-healthcare has provided a framework for a person-centered 
approach, which focuses treatment on being more inclusive of the patients’ preferences 
and personally relevant goals.  Treatment adherence was measured by participants’ 
answers to specific questions pertaining to their psychiatric appointment attendance and 
the frequency of their taking their psychiatric medications as prescribed.   
Design 
 
This researcher used a longitudinal archival data set comprised of self-report 
surveys.  Archival data were chosen because they contain the de-identified data, which 
allows for the participants’ confidentiality to be upheld and do not require the researcher 
to obtain individual consents.  A correlational design was chosen because it enables 
researchers to analyze the relationships among numerous variables in one study, it allows 
for a large sampling size to be used, it allows for prediction of participants’ scores on one 
variable based on their scores on other variables, and it enables researchers to gain and 
examine information regarding the degree of the relationship between variables.  
Furthermore, using archival data places fewer burdens on participants, and it allows for 
the ability to obtain more attitudinal data from a variety of people. 
Participants 
 
The original eligibility criteria for the participants of the current study included 
primary diagnosis of a schizophrenia spectrum disorder, age of 18 years and older, and 
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currently receiving psychiatric medication prescriptions from a mental-health agency.  
Participants’ eligibility was verified through chart reviews to ensure their status on 
inclusion criteria had not changed.  
Data were obtained from the SAMHSA/ Mental-health Disparities Multisite 
Research Initiative through a data-sharing agreement.  According to researchers from the 
Disparities Initiatives, their data were obtained from four mental-health agencies in the 
Philadelphia area.  Each agency produced a complete list of its consumers who met the 
study’s eligibility criteria.  The majority of the consumers were Medicare and Medicaid 
recipients (Salzer, Brusilovskiy, Rothbard, & Haley, 2007). 
The participants included in the original dataset had primary psychiatric diagnoses of 
either major depressive disorder or a schizophrenia spectrum disorder.  According to the 
researchers from the Mental-health Disparities Initiative, the included diagnostic from the 
American Psychiatric Association’’s Diagnostic and Statistical Manual of Mental 
Disorders, 4
th
 edition, text revision are as follows: 296.3x, 295.30, 295.10, 295.20, 
295.90, 295.60, and 295.70 (Salzer et al, 2007).   
For purposes of the current study, the participants with a depressive disorder were 
excluded (296.3x).  This researcher was interested in a homogeneous population of 
people with psychotic disorders.  The rationale is that people with psychotic disorders can 
have a more severe symptomatic presentation, and they are likely more stigmatized by 
the general public and, potentially, by treatment providers.   
Schizophrenia spectrum disorders include the DSM-IV-TR diagnoses of 
schizophrenia, schizoaffective disorder, and psychotic disorder not otherwise specified.  
These disorders are characterized by thought disturbances, most commonly manifesting 
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as hallucinations and delusions.  Other common symptoms for people with schizophrenia 
spectrum disorders are disorganized speech, disorganized or catatonic behavior, and gross 
impairment in reality testing.  In order for these symptoms to be diagnosed as a psychotic 
disorder, they must result in significant functional impairment in one or more major areas 
of one’s life, including social, occupational, and interpersonal functioning (4th ed., text 
rev.; DSM-IV-TR; American Psychiatric Association, 2000).   
Measures 
Four predictor variables and three outcome variables were used, as measured by 
the scales described as follows. 
The Recovery Assessment Scale-Short Form (RAS-SF; Corrigan, Salzer, Ralph, 
Sangster, & Keck, 2004) was developed from the original Recovery Assessment Scale 
(RAS; Corrigan et al., 2004).  The RAS was developed to operationalize the construct of 
recovery, which includes elements of hope, empowerment, and quality and meaning of 
life.  The RAS has been used to measure levels of perceived recovery-oriented services 
that people with serious mental illness were receiving and to measure recovery variables 
as outcome measures for mental-health consumers in Australia.  “The RAS was factor 
analyzed, and the five factors identified included personal confidence and hope, 
willingness to ask for help, goal and success orientation, reliance on others, and no 
domination by symptoms” (Corrigan et al., 2004, p.1038).  Each factor was found to have 
satisfactory internal reliability.  Each factor was also found to have convergent validity 
with regard to accurately measuring the construct of recovery.  Furthermore, the RAS 
was found to be reliable and valid overall and theoretically adequate for measuring the 
components that comprise the construct of recovery (McNaught, Caputi, Oades, & 
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Deane, 2007).  The RAS-SF is comprised of all five factors, but only five of the nine 
original questions from Factor 1 were incorporated into the short form.  The RAS-SF 
consists of 20 questions on a Likert scale, with five possible responses ranging from 
strongly disagree to strongly agree.   
The Participatory Decision-making Scale (PDMS) was developed by Kaplan et 
al. (1995) to measure the amount of involvement patients have in their treatment-related 
decision-making process with their physicians (Cooper-Patrick, Gallo et al., 2009). The 
scale consists of three items: “If there were a choice between treatments, how often 
would this psychiatrist ask you to help make this decision?”  “How often does this 
psychiatrist give you some control over your treatment?”, and “How often does this 
psychiatrist ask you to take some of the responsibility for your treatment?”  These 
questions can be responded to on a scale of 1 to 4, ranging from never to very often.  This 
scale has been used in studies to determine differences in the quality of mental-health 
service delivery in relation to physician race and gender (Cooper-Patrick et al., 2009).  To 
date, no reliability and validity information is available for this scale. 
The Empowerment (POW) scale is a consumer-constructed scale for measuring 
the construct of empowerment.  It has been tested for reliability and validity and factor 
analyzed (Rogers, Chamberlin, Ellison, & Crean, 1997).  This scale was developed to 
operationalize the construct of empowerment, which has been found to be positively 
related to quality of life and community activism.  It consists of 28 questions on a Likert 
scale, ranging from strongly agree to strongly disagree.   The factor analysis revealed 
five distinct factors measured by this scale: “self-efficacy and self-esteem, power-
powerlessness, community activism, righteous anger, and optimism-control over the 
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future” (Rogers et al., 1997, p. 1042).  The researchers concluded that the scale is 
internally consistent and there is evidence supporting its validity (Rogers et al., 1997). 
Attitudes Toward Treatment (ATT) scale is a measure that was derived from the 
Perceived Coercion Scale and the Admission Experience Survey (Gardner et al., 1993). 
This measure is based on patients’ perceptions of being coerced into receiving mental-
health treatment.  The researchers used a correlation analysis to develop this survey.  
These scales have been used to assess perceptions of coercion of mental-hospital 
inpatients (Gardner et al., 1993).  The questionnaire asks participants to self-report levels 
of how much choice, influence, freedom, and control they feel they had regarding their 
admission to mental-health hospitals.  The researchers found patients’ responses to be 
internally consistent and robust throughout a variety of locations, patient populations, 
questionnaire formats, and interview procedures.  The ATT scale consists of five items in 
a true-or-false format.  The questions read as follows:   
1. I felt free to do what I wanted about going to mental-health 
treatment?  2. I chose to go to mental-health treatment?  3. It was my 
idea to go to mental-health treatment?  4. I had a lot of control over 
whether I went to mental-health treatment?  5. I had more influence 
than anyone else on whether I went to mental-health treatment? 
(Mental-health Disparities Initiative Protocol Version 1.8, 2004, p. 21).   
These questions were adopted verbatim from the Perceived Coercion Scale, 
except for the words “mental-health treatment” replacing the word “hospital” in the 
original format (Gardner et al., 1993).  
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Two items from the interview protocol were used to measure the outcome of 
appointment adherence: “How many mental-health appointments (with your psychiatrist) 
have been scheduled for you in the past six months?” and “How many of these 
appointments have you missed in the past six months?” A variable was created to 
determine the percentage of scheduled appointments attended per participant.  
Adherence to psychotropic medication was measured by two separate questions 
from the interview protocol: “In general, how well do you currently take medications as 
they are prescribed for you by your doctor?” and “How often have you taken your 
antipsychotic medication as prescribed by the doctor over the last four months?”  The 
range of the Likert scale measuring medication adherence was Extremely Well to I rarely 
take my medications. 
Procedure 
 
The following procedural information from the original study was obtained 
through personal communication with the Mental-health Disparities Initiative 
researchers:  
Research staff directed agency staff at each agency to approach their clients to 
inform them about the study and gain their permission for research staff to contact 
them.  Agency staff completed a ‘Consent-to-Contact’ (CTC) form that was then 
returned to the research staff.  All clients who consented to speak to the research 
staff were contacted and informed about the study.  If they agreed to participate, 
they provided written consent, completed baseline measures, and were 
randomized to either the experimental or control condition.  Each participant 
enrolled in the study was assigned a sequential Participant ID#. . . Participants 
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assigned to the experimental condition were referred to the interventionists at 
their agency for the self-care intervention. Additional follow-up interviews were 
conducted at 6 and 12 months after the baseline interview.  Each participant 
received 20 dollars for completion of each individual interview and an additional 
20 dollars if they completed all three interviews” (Salzer et al., 2007, pp. 5-6).   
 The treatment administered in the study from which these data were originally 
obtained showed no significant effects; therefore, the data is appropriate to be used to 
explore the presence of other hypothesized correlations (Salzer et al., 2007).  The original 
researchers reported the following information regarding their participant recruitment:  
We were able to maintain good retention rates at each of the follow-up points as 
indicated by rates above 80%. We used a strategy that included obtaining locator 
information for each client at the time of consent.  This information was reviewed 
and updated in each meeting with the participant at the 4-month & 10-month 
phone contact points that we used to maintain contact with a highly mobile 
population.  In addition to personal contact information, collateral contact 
information was also collected, including participant identification of collateral 
contacts who could be called if we were unable to find the participant at the time 
another interview needed to be conducted (Salzer et al., 2007, pp. 5-6).   
See Table 2 for multimatrix correlations of independent and dependent variables. 
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Table 1 
Distribution of Participant Recruitment 
Agency N = Baseline N = 6 month Retention 
rate 
N = 12 month Retention rate 
A 104 95 91% 88 85% 
B 109 101 93% 87 80% 
C 88 68 90%* 30 89% 
D 95 84 88% 79 83% 
Note. Adapted from “A Randomized, Controlled Study of a Telephone-based intervention to Reduce 
Disparities Through Enhanced Self-care, Patient-Physician COmmuniction, and Motivation to Participate 
in Treatment,” by M.S. Salzer, E. Brusilovskiy, A. Rothbard, and T. Hadley is due to date.” (p. 5-6, Salzer, 
Brusilovskiy, Rothbard, 2007, pp. 5-6. Copyright 2007.   
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Analytic Strategy and Statistical Methods 
In his article, “a Power Primer,” Cohen (1992) suggested .15 as a medium effect 
size for multiple and multiple partial correlations.  Conventionally, a medium effect size 
is selected if previous studies have not reported effect sizes or if no previous research on 
a specific research domain for a multiple regression analysis exists (Faul & Erdfelder, 
1992); therefore, .15 as a medium effect size was used in the current study.  No meta-
analysis on appointment treatment adherence could be located.  Using four substantive 
predictors, α = .05, f2 = - .15, and power set at .80, a sample size of 215 participants was 
considered acceptable for this model.  However, the final regression analysis included 
four substantive predictors and three control variables that were determined by bivariate 
correlations with the respective outcome variables.  
The primary goal of the present study was to determine if four predictor variables 
were correlated with three outcome variables. Each of two hypotheses was tested using a 
regression analysis.  Each hypothesis had one outcome variable that was continuous.  The 
outcome variables were quality of medication adherence, frequency of medication 
adherence, and mental-health appointment attendance.  The outcome variables were self-
reported responses of how often the participants missed an appointment, how well they 
believed they adhered to their medication regimen, and how frequently they adhered to 
their psychotropic medication regimen.  The four predictor variables were also 
continuous variables.  They were scales aimed to measure constructs of interest that are 
theoretically linked to the recovery movement.  The predictors were hypothesized to be 
positively correlated with each outcome variable.   
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First, the data were checked to ensure they met all of the assumptions needed for 
multiple regressions.  For example, a correlation matrix was run between each predictor 
variable (4 x 4 design) to rule out multicorelliniarity among the predictors.  The 
correlations between the predictor variables should not exceed 0.9.  If two of the 
predictor variables are determined to be measuring the same construct, both would not be 
needed.  Next, additional data screening was conducted to ensure the data met all of the 
assumptions required for running regression analyses.  The assumptions were met by 
conducting all of the tests recommended by Osborne and Waters (2002), including 
assuring that all of the variables were normally distributed, there was a linear relationship 
between the independent and dependent variables, the variables were measured reliably, 
and there was homoscedasticity.  
The third step was entering the values from the scales that measure the predictor 
variables.  This step was the completion of the multiple regressions to test the hypotheses 
that consumers with schizophrenia spectrum disorders will attend more mental-health 
appointments and take their prescribed psychotropic medication more often if they 
perceive their services to be recovery-oriented, if they perceive their treatment to involve 
PDM and empowerment, if they perceive their providers as skilled and culturally 
competent, and if they have positive attitudes toward receiving medical and psychiatric 
treatment at the baseline time measurement point.   
The first multiple regression was conducted where PDM, higher levels of 
empowerment, higher levels of recovery attitudes, higher levels of perceived provider 
skills and cultural competence, and positive attitudes towards treatment were predictor 
variables and mental-health appointment attendance was the outcome variable. 
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A second multiple regression was conducted where PDM, higher levels of 
empowerment, higher levels of recovery attitudes, higher levels of perceived provider 
skills and cultural competence, and positive attitudes towards treatment were predictor 
variables and quality and frequency of medication adherence were the outcome variables. 
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Chapter 4: Results 
Participants 
Excluded Participants. 
All of the data were checked for accurate entry.  The original sample was 
comprised of 238 participants.  Data from participants who did not complete at least 90% 
of each scale included in the main analyses were excluded because they were considered 
incomplete and likely invalid (Schlomer, Bauman, & Card, 2010).  Ten participants were 
excluded because they did not complete the PDMS scale, five more were eliminated for 
incomplete POW scales, three additional participants were eliminated for incomplete 
RAS-SF scales, and four were eliminated for incomplete ATT scales. In total, 22 
participants’ data were excluded because those participants had not completed at least 
90% of each predictor scale. One participant failed to answer the questions regarding 
medication adherence, and this person’s data were excluded from the analyses. The final 
number of participants with valid data was 215.  The eliminated participants’ data were 
checked against the included participants’ data for significant differences on each of the 
independent variables (POW, PDMS, ATT, RAS-SF), the dependent variables 
(appointment attendance, medication adherence quality and frequency), and the variables 
from the literature that had previously been found to be associated with treatment 
adherence (i.e., age, gender, substance abuse, symptom severity, quality of life, attitudes 
toward psychiatric treatment, and length of treatment).  There were no significant 
differences between the 215 participants and the 23 participants who were excluded for 
incomplete questionnaire entries.  
RECOVERY MOVEMENT AND TREATMENT ADHERENCE 48 
 
 
Overall Background. 
The final sample was comprised of 215 participants.  Of these participants, 100 
(46.5 %) were female and 115 (53.5%) were male.  Participants described their ethnicity 
as White 31.2% (N = 67), Black 68.4% (N = 147), Latino or Hispanic 0.9% (N = 2), 
Native American 16.7% (N = 36), Native Hawaiian or other Pacific Islander 0.5% (N = 
1), Asian 1.9% (N = 4), and any other ethnicity 4.7% (N = 10).  The majority of the 
participants had never been married (69.8%, N = 150), 8.8% (N = 19) were widowed, and 
17.2% (N = 37) had significant others to whom they were not married at the time of the 
interview.  Some of the participants had natural, adopted, or stepchildren under the age of 
18 years (16.8%, N = 36); however, only about half of those participants reported having 
responsibility for caring for those children (9.4%, N = 20).  Almost half of the 
participants completed between 9 to 12 years of school (30.7%, N = 66), and 13.0% (N = 
28) completed fewer than 9 years of school.  About one third of the participants 
graduated from high school or received a GED (33.5%, N = 72), and 18.3% (N = 40) 
attended some college or vocational, trade, or business school.  Five participants (2.3%) 
graduated from college, and one (0.5%) had some master’s-level education.  Many of the 
participants reported working in some capacity (full time, N = 7 [3.3%]; part-time, N = 20 
[9.3%]), or that they were students (N = 24, 11.2%) or retired (N = 37, 17.2%).  However, 
some of these same participants considered themselves to be disabled, as 168 (78.1%) 
total participants endorsed being disabled, and 180 (83.7%) unemployed. 
The length of time participants had been with the agency that was providing their 
mental-health treatment at the time of data collection ranged from 3 to 441 months.  The 
average length of time participants’ had been receiving treatment was 98.50 months (8.21 
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years; M = 98.50, SD ± 95.65).  Participants rated their general satisfaction levels with 
the mental-health program they were currently attending by responding to the question, 
“In general, I am satisfied with this/ these program[s],” on a Likert scale, with 1 = 
strongly agree, and 5 = strongly disagree, (M = 1.70 , SD = .834).  This result showed 
that, overall, participants felt very positive about their experience/s with their current 
providers.  See Figure 1 for a flow chart regarding participant retention. 
 
Figure 1.  Participant Recruitment and Exclusion 
 
 
 
 
 
 
 
Number of Participants Eligible from all four sites  
N = 1771 
Disparities Data Set (Original Data set) 
 
Number of Participants Approached from all four 
sites  N = 501 
Disparities Data Set (Original Data set) 
 
Number of Participants Consented and Enrolled from 
all four sites  
N = 396 Disparities Data Set (Original Data set) 
 
 
Current Study 
Baseline Data from Original Study obtained from 
participants N = 396 
 Participants Excluded for not having a 
diagnosis of schizophrenia N = 238 
23 Participants Excluded for 
incomplete measures N = 215 (final) 
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Dependent Variables 
Background characteristics of appointment attendance   
Of the 215 individuals in the current study, all reported that they had scheduled at 
least one appointment in the previous 6 months.  The range of scheduled appointments 
per participant was 1 to 24 (M = 5.84, SD = 2.67).  The percentages of missed 
appointments per participant ranged from 0 to 100% (M = 9.3%, SD = 19%).  No 
significant differences were noted for appointment adherence due to age, gender, 
attitudes toward psychiatric treatment, substance abuse history, or length of treatment at 
the current provider at the time the baseline data were gathered. After preliminary 
analyses of all of the variables noted in the literature to be associated with the outcome 
variables, two variables were determined to be significantly associated with the outcome 
variable of appointment attendance in the current data set.  The variables of symptom 
severity and quality of life were significantly correlated with appointment attendance  
r (213) = .173, p <.05; and r = - .167, p <.05, respectively.  These variables were used in 
the main analysis of appointment adherence to control for their effects.  See Table 2 for 
percentages and statistical tests between variables that were found to be significantly 
associated with outcome variables. There was no significant correlation between the 
predictor scales (RAS-SF, PDMS, ATT, POW) and appointment adherence.   
Background characteristics of medication adherence  
Medication adherence was measured by two self-report items from the questionnaire.  
Quality of adherence to prescribed medication was measured by the question, “In general, 
how well do you currently take medications as they are prescribed by your doctor?”  The 
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range of the Likert scale measuring quality of medication adherence was 1 = Extremely 
Well to 5 = I rarely Take my medications (M = 1.64, SD = .814).   
A significant correlation found was between the predictor scales and quality of 
medication adherence.  The POW scale was found to be positively correlated with quality 
of medication adherence, r (213)  = .148, p < .05.  The more empowered participants 
rated themselves, the higher the quality of medication adherence they reported.  See 
Table 1 for bivariate correlations of predictor variables and quality of medication 
adherence. 
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Table 2 
Multimatrix Correlations of Independent and Dependent Variables 
Measure 1 2 3 4 5 6 7 8 9 10 
1. POW 1 -.157* -.208** -.633 -.02 .088 .040 .130 -.246** .228 
2.PDMS -.157* 1 .087 .213** .012 -.103 -.013 -.019 .111 -.243** 
3. ATT -.208** .087 1 .146* -.002 -.069 -.073 -.030 .121 -.177** 
4. RAS-SF -.633** .213** .146* 1 -.095 -.069 -.060 -.309** .473** -.268** 
5. APPT .088 .012 -.002 -.095 1 .154* .208** .173* -.167* .069 
6. MEDQ .148* -.157* -.069 -.069 .154* 1 .466** .094 .065 .334** 
7. MEDF .040 -.013 -.073 -.060 .208** .466** 1 .102 -.114 
 
.251** 
8. CSI .130 -.019 -.030 -.309 .173* .094 .102 1 -.309** .103 
9. QOL -.246** .111 .121 .473** -.167 .065 -.114 -.309** 1 -.175* 
10. ATPT .228** -.243 -.177** -.268** .069 .334** .251** .103 -.175 1 
Note. POW = Empowerment; PDMS = Participatory Decision-making; ATT = Attitudes Toward Treatment 
scale; RAS-SF = Recovery Assessment Scale-Short Form; APPT = Appointment Nonadherence; MEDQ = 
Medication Adherence Quality; MEDF = Medication Adherence Frequency; CSI = Colorado Symptom 
Index (symptom severity); QOL = Quality of Life; ATPT = attitudes toward psychiatric treatment. 
*p < .05. **p < .01. 
The ATT scale was found to be significantly correlated with quality of medication 
adherence, r (213)  = - .334, p <.01.  The more positive the attitude toward treatment the 
participants reported, the higher quality of medication adherence they reported.  No 
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significant differences were found for quality of medication adherence due to age, 
gender, symptom severity, substance use, length of treatment at the current mental-health 
agency, or quality of life at the time of administration of the baseline questionnaire.  See 
Table 2 for percentages and statistical tests between variables that were found to be 
significantly associated with self-reported quality of medication usage.   
Frequency of medication adherence was measured on a Likert scale by one item 
on the questionnaire: “How often have you taken your antipsychotic medication as 
prescribed by the doctor over the last four months?” Responses ranged from, 1 = I never 
miss taking my medication to 5 = I stopped taking my medication altogether.  The scores 
on the frequency of medication item had a range of 4 (M = 1.50, SD = .791).   
No significant differences were noted for frequency of medication adherence due to 
age, gender, symptom severity, substance abuse history, length of treatment at the current 
mental-health agency, or quality of life at the time of administration of the baseline 
questionnaire. 
See Table 1 for percentages and statistical tests between variables that were found to 
be significantly associated with self-reported frequency of medication usage.   
No significant correlations were found between the predictor scales and frequency of 
medication adherence. 
Empowerment, PDM, Attitudes Toward Treatment, and Recovery Assessment 
Significant correlations were found among the predictor scales. The POW scale was 
found to be negatively correlated with the ATT scale, the RAS-SF, and the PDM scale 
r(213)  = - .208, p < .01; , r (213) = - .633, p < .01; r (213)  = - .157, p < .05; respectively.  
This was expected, as a lower score on the POW scale indicates the person self-reports as 
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more empowered.  Higher scores on the PDMS, ATT, and RAS-SF indicate increased 
participatory decision-making, more positive attitudes, and higher on recovery measures.  
Additionally, the Recovery Assessment Scale was found to be positively correlated with 
the PDM scale and the ATT scale r (213) =.213, p < .01; r (213)  = - .146, p < .05; 
respectively.   
See Table 3 for means and standard deviations for treatment adherence and recovery 
measures.  
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Table 3 
Means and Standard Deviations for Treatment Adherence and Recovery Measures  
           Measure M SD 
POW 2.06 .33 
PDMS 8.16 2.28 
ATT .75 .29 
RAS-SF 3.98 .49 
APPT .09 .19 
MEDQ 1.64 .81 
MEDF 1.50 
 
.79 
 
 
Note. POW = Empowerment; PDMS = Participatory Decision-making; ATT = Attitudes Toward 
Treatment; RAS-SF = Recovery Assessment Scale-Short Form; APPT = Appointment Nonadherence; 
MEDQ = Medication Adherence Quality; MEDF = Medication Adherence Frequency.  
Assumptions for Multiple Regression 
The data were tested for meeting the assumptions for multiple regression analysis.  
Each independent and dependent variable was quantitatively measured, and they had 
some variation in value.  No multicollinearity was found among the predictor variables 
(0.9 or higher).  The highest correlation found between any two of the five predictors was 
between the RAS-SF and the POW scale, r (213)  = - 0.71.  Preliminary analyses 
determined that the variables had homoscedasticity.  The residuals were found to have the 
same variance at each level of the predictor variables.  The residuals were also found to 
be random and normally distributed.  (The differences between the model and the data 
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were found to be zero).  The final assumption for which the data were checked was 
linearity.  The relationships between the mean values of the outcome variables were 
found to be linear.  (The mean values of the outcome variables lay upon a straight line for 
each increment of the predictor variable.)  
Dependent Variables Multivariate Analyses 
Predicting appointment adherence.  The first hypothesis tested the predictive power of 
variables theoretically selected to encompass recovery principles to examine if these 
variables could account for an individual’s likelihood to adhere to scheduled mental-
health appointments.  Variables that were found to be significant in the initial data 
analyses symptom severity and quality of life were entered to control for possible 
confounding effects variables on the first step of the hierarchical multiple regression 
analysis.  
The variables for the recovery principles (empowerment, recovery attitudes, 
attitudes toward treatment, PDM) were entered on the second step of the hierarchical 
regression analysis.  Results indicated that participants’ self-reported levels of the degree 
to which their mental-health treatment aligned with recovery principles was not a 
significant predictor of the appointment attendance.  Results showed that the first block 
containing the identified confounding variables was significant (p < .008); however, it 
accounted for only 4.4% of the variance in appointment adherence.  Adding the recovery 
predictor variables on Step 2 of the model resulted in an insignificant increase of 0.5%, to 
a total of 4.9% of the variance in appointment attendance being accounted for by all 
variables in the models.  However, this second model did not remain significant.  Further 
inspection of the results indicated that in both models, quality of life and symptom 
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severity (p > .085 and p > .060, respectively) contributed most to appointment adherence.  
No other variables contributed in a statistically significant way to appointment 
attendance.  
Predicting medication adherence.  The second hypothesis tested the predictive validity 
of the recovery principle scales on participants’ adherence to their psychotropic 
medication regimen.  Two items from the interview protocol were used to measure the 
outcome of medication adherence.  One was determined to measure quality of medication 
adherence: “In general, how well do you currently take medications as they are 
prescribed by your doctor?”  The second question was determined to measure frequency 
of medication adherence: “How often have you taken your antipsychotic medication as 
prescribed by the doctor over the past four months?”  The second hypothesis tested the 
predictive power of variables theoretically selected to encompass recovery principles 
(empowerment, recovery assessment, attitudes toward treatment, PDM) to examine if 
these variables could account for an individual’s likelihood to adhere to his or her 
medication regimen.   
Multivariate Analysis Quality of Medication Adherence.  The variable that 
was found to be significantly correlated with quality of medication adherence in the 
initial data analyses (attitudes toward psychiatric treatment) was entered to control for 
possible confounding effects on the first step of the hierarchical multiple regression 
analysis.  The variables for the recovery principles (empowerment, recovery attitudes, 
attitudes toward treatment, PDM) were entered on the second step of the hierarchical 
regression analysis, and results indicated that participants’ self-reported levels of the 
degree to which their mental-health treatment aligned with recovery principles was not a 
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significant predictor of the quality of medication adherence.  Results showed that the first 
block containing the identified confounding variables was significant (p < .000); 
however, accounted for only 1.1% of the variance in quality of medication adherence.  
Adding the recovery predictor variables on step 2 of the model resulted in an insignificant 
increase of 0.1% to a total of 1.2% of the variance explained in appointment attendance 
by all variables in the models.  This second model remained significant at the p < .000.  
Further inspection of the results indicated that in both models attitudes toward psychiatric 
treatment (p > .000) contributed to the variance in the quality of medication adherence.  
No other variables contributed in a statically significant way to quality of medication 
adherence.  
Multivariate Analysis Frequency of Medication Adherence.   
The variable that was found to be significantly correlated with frequency of 
medication adherence in the initial data analyses (attitudes toward psychiatric treatment) 
was entered to control for possible confounding effects on the first step of the multiple 
regression analysis (ATPT).  The variables for the recovery principles (empowerment, 
recovery attitudes, attitudes toward treatment, PDM) were entered on the second step of 
the regression analysis.  Results showed that the first block containing the identified 
confounding variables was significant (p < .000) and accounted for 6.3% of the variance 
in frequency of medication adherence.  Adding the recovery predictor variables on step 2 
of the model resulted in an insignificant increase of 0.4%, to a total of 6.7% of the 
variance explained in frequency of medication adherence by all variables in the models.  
This second model remained significant (p > .012).  Further inspection of the results 
indicated that in both models, attitudes toward psychiatric treatment (p > .000) 
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contributed to frequency of medication adherence. No other variables contributed in a 
statically significant way to frequency of medication adherence.  Table 4 displays the 
sequential regression results.  
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Table 4 
Sequential for Logistic Regression of the Recovery Model and Treatment Adherence  
 
 
Model R Square df p Model 
changed r 
square 
Model 
changed df 
Model 
changed p 
APPT .044 214 .008* .049 214 .104 
MEDQ .111 214 .000** .124 214 .000** 
MEDF .063 214 .012* .067 214 .012* 
Note. APPT = Appointment Nonadherence; MEDQ = Medication Adherence Quality; MEDF = Medication 
Adherence Frequency.  
*p < .05. **p < .01. 
 
Additional Analyses 
The three outcome measures (appointment attendance, quality of medication 
adherence, and frequency of medication adherence) were found to be positively 
correlated with each other.  The more often patients took their medication (frequency of 
medication adherence), the more often they attended appointments, r(213) = .208, p < 
.01.   The higher the quality of medication adherence the patients reported (quality of 
medication adherence), the more often they attended appointments, r (213) = .154, p < 
.05.  Quality and frequency of medication adherence were also found to be positively 
correlated, r(213) = .466, p < .01. 
A question was provided to determine why the participants did not take their 
medications.  Participants were asked, “Which of the following were reasons for not 
RECOVERY MOVEMENT AND TREATMENT ADHERENCE 61 
taking your medications?” The options for responses that were provided by the 
questionnaire were as follows: “Not understanding the instructions from the physician” 
(N = 7, 2.3%); “Disagreeing with recommendations of the doctor” (N = 8, 2.7%); 
“Forgetting” (N = 91, 30.4%); “Having too many side effects” (N = 16, 5.4%); “Side 
effects too severe” (N = 18, 6%); “Running out of meds and not yet refilled” (N = 32, 
10.7%); “Medication too expensive” (N = 7, 2.3%); “Not needing them” (N = 17, 5.7%); 
“Feeling better” (N = 22, 7.4%); “Symptoms being too severe” (N = 11, 3.7%); “Others 
telling me not to” (N = 4, 1.3%); “Not wanting symptoms to go away” (N = 3, 1.0%).  
An open-ended question was also provided for participants to explain why they did not 
take their medications. Among the qualitative responses provided were statements such 
as “having an empty stomach,” “having health concerns,” “not wanting to fall asleep,” 
“getting tired of taking the medications,” and “having issues with timing of the dosages.” 
The participants were also asked, “Which of the following are reasons for missing 
any appointments? Did you miss appointments because….”  The options for responses 
that were provided by the questionnaire were as follows: “You forgot” (N = 26, 12.1%); 
You have a negative relationship with physician” (N = 4, 1.9%); “You had no 
Transportation” (N = 12, 5.6%); “Family/friend told you not to go” (N = 0, 0%); “You 
felt embarrassed about going” (N = 4, 1.9%); “You didn’t feel like going” (N = 13, 
6.0%); “You don’t have a mental illness” (N = 2, 0.9%); “You didn’t want your 
medications/shot” (N = 4, 1.9%).  An open-ended option was also provided.  A total of 30 
participants provided an answer, and some of those responses were as follows: being 
tired, sick, or not feeling well; oversleeping; having a conflicting appointment; having a 
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family member in the hospital; or having other conflicts with their schedule.  The most 
common open-ended response was that the participant had been in the hospital.  
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Chapter 5: Discussion 
 
The current study investigated if constructs aligned with the recovery model of 
mental-health treatment were predictive of treatment engagement.   Increasing treatment 
engagement is at least partially associated with reduced exacerbation  of psychiatric 
symptoms, reduced readmission to inpatient psychiatric and medical hospitalizations, 
decreased homelessness, less violence toward other people, and reduced healthcare costs 
(Dolder et al., 2004; Valenstein et al., 2002).  
 The current research investigated if recovery-aligned constructs have predictive 
validity to provide an explanatory framework for psychotropic medication adherence and 
psychiatric appointment attendance for individuals diagnosed with schizophrenia.  Four 
predictor scales, which were theoretically linked to the principles of the recovery model, 
were used to determine the extent to which participants perceived their treatment to be 
aligned with the recovery model.  The model was tested separately for each outcome 
variable. 
Appointment Attendance 
The model tested in the current study was not found to be predictive of 
appointment attendance.  Two possible explanations for the lack of significant effect 
could be the levels of self-reported adherence to appointments were generally high and 
that the majority of the study participants had a long treatment history with their current 
providers.  On average, the participants had been with their providers for 8 years.  This 
amount of time constitutes an unusual sample to investigate regarding treatment 
adherence, given that individuals who may have initial treatment engagement problems 
likely would have long ago stopped attending the program.  The majority of research on 
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treatment engagement has focused on gaps and problems with service linkages (inpatient 
to outpatient) or with initial engagement in outpatient services (first appointment or 
engagement over the first several appointments).   Studies on the prediction of reasons for 
appointment attendance in populations with serious mental-health problems over the long 
term are less often conducted.  However, the predictors of appointment adherence have 
been shown to be multifaceted, linked to medication adherence, and can be improved 
when perceived PDM and satisfaction for treatment are low (Mitchell & Selmes, 2007 ).   
In the current investigation, participants reported being very satisfied with their 
treatment, regardless of how recovery-oriented they perceived it to be, which provides 
further indication that the sample is mostly adherent to their treatment.   Many barriers 
that have been linked in the literature to appointment attendance probably had already 
been addressed, including transportation, insurance reimbursement, and other financial 
and scheduling concerns.  The current treatment received by the participants was likely 
part of their routine, and they likely had established relationships with the providers 
(Killapsy et al., 2000).  Furthermore, the participants generally reported high levels of 
quality of life when they were attending appointments, which further suggests that they 
were satisfied with their current treatment providers. 
Of the total 215 participants, only 60 reported having missed any appointments.  
Furthermore, 49 of those 60 reported missing only one or two appointments, and the 
other 11 people missed from three to six appointments. While these 11 individuals may 
constitute an important subgroup of more significantly nonadherent study participants to 
investigate, this number of individuals was too small to conduct any meaningful 
comparisons.  In the entire sample, the clinical significance of appointment 
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nonattendance was low.  The mean number of scheduled appointments was close to six, 
so on average, once-monthly appointments were scheduled, and most people who missed 
any appointments, missed only one.  Missing one or two appointments in a 6-month 
period of time seems reasonable for any population, especially those with a severe mental 
illness, and is therefore not necessarily indicative of service disengagement.  The 
researcher should note however, that any missed appointment can be the first warning 
sign of a possible dropout and subsequent complete treatment disengagement.  However, 
complete disengagement seems not to have been the case in this population, as many 
individuals who reported missed appointment/s had clearly re-engaged with the provider 
at the time of the data collection.  Previous literature supports the idea that the 
participants in the study generally reported nonproblematic levels of appointment 
nonadherence.  Results from previous research of treatment nonadherence for people with 
schizophrenia disorders reported that the appointment nonattendance rate is about 26% 
(Nose et al., 2003).  Appointment adherence rates are slightly better for those recently 
discharged from inpatient psychiatric hospitalization, at 18% of appointments missed 
(Kruse et al., 2002).  This finding supports the hypothesis that the particular sample used 
in the current study represents people who have been with the same treatment provider 
for a long period of time, and therefore were likely to have established and satisfactory 
relationships and may not have significant concerns about their prescribed medication 
regimens, or at least may feel that they can address these concerns with their providers. 
The qualitative data of this study indicated that only a very small number of 
individuals (N = 4) reported concerns about their medications as a reason for missing any 
of their appointments.  This finding may result in levels of adherence to appointments 
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that are even better as compared to the average rate of appointment attendance of 
individuals with medical conditions, found to be at 58% (Mitchell & Selmes, 2007), and 
is better than the rate for individuals with schizophrenia who are discharged from an 
inpatient stay, starting out with a new treatment provider, or have been with a provider to 
whom they do not particularly feel connected. 
Most of the variance in participants’ appointment attendance was predicted by 
symptom severity and quality of life.  The current study found symptom severity to have 
a significant positive effect on treatment adherence, which is contradictory to most 
suggestions in previous literature regarding the relationship between these two variables.  
Most research on psychiatric treatment adherence has found increased symptomatology 
to be associated with increased rates of treatment dropout and not attending scheduled 
appointments (Killaspy et al., 2000).   A potential reason for the discrepancy in the 
findings might again be explained by the characteristics of the sample used in the current 
study.  People who tend to drop out of treatment altogether likely were not captured in 
this sample, and most of the individuals included likely had a well-established and 
positive relationship with their treatment providers.  Such a relationship limited the 
amount of variability in the participants’ responses to the independent variables used to 
measure the recovery orientation of the treatment providers.  Moreover, the participants 
generally reported high levels of satisfaction with their treatment providers, and they 
generally had high frequencies of attending appointments (most missed only one or two 
appointments in 6 months).  Moreover, those participants who had high attendance rates 
also reported high levels of quality of life.  Therefore, the results indicate that treatment 
nonadherence was not largely problematic in the sample, and this sample may have not 
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been representative of the larger population of individuals with schizophrenia.  Another 
potential explanation for the effect of symptom severity is that people may believe they 
benefit more from treatment when they have exacerbations in their symptomatology.  
People could also be more motivated to attend appointments when their symptoms are 
exacerbated because their medications are being adjusted, and thus the desire to become 
stabilized and increase their functioning could be more salient.  Another possible 
explanation is that exacerbated positive symptoms could serve as reminders to attend 
appointments.  The opposite effect of symptom severity on appointment adherence was 
found by Killapsy et al. (2000).  These researchers found that when people failed to 
attend outpatient appointments, they were more unwell and socially impaired than those 
who attended their appointments.  These researchers found participants with diagnoses of 
schizophrenia or schizoaffective disorder to be at higher risk of missing follow-up 
outpatient appointments than those with other diagnoses.   
Killapsy et al.  suggested that people with schizophrenia spectrum disorders 
experience more severe social isolation and symptomatology that contributes to 
nonattendance, such as paranoia, depression, apathy and other negative symptoms, 
reduced organizational skills, and lack of insight.  Their findings are clinically relevant 
because patients’ nonattendance can be addressed early on in treatment in an attempt to 
prevent future missed appointments.  The researchers’ outcomes provide support for the 
effectiveness of intervening upon a patient’s first instance of not attending.  Forgetting 
was the most common reason for not attending appointments reported by the psychiatric 
patients, and was twice the rate of patients who reported forgetting as a reason for 
missing medical appointments.  Forgetting was also mentioned by 26 participants for 
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missing appointments and by 91 participants for missing medication in the current study.  
Appointment attendance is an important part of psychiatric treatment, and the 
forgetfulness can be addressed using technology, such as smart-phone reminders.  Recent 
research has supported the use of digital technology to remind patients to attend 
appointments and take their medication (Ben-Zeev, Davis, Drake, Kaiser, & Krzsos, 
2013).  These researchers provided their participants with digital assistant devices such as 
smart phones or personal digital assistants, and found that the devices helped them adhere 
to their treatment and to checkin with their providers regarding their progress.  Given the 
quickly developing digital age, research and treatment need to keep up with available 
technology to help people access and adhere to the available forms of care (Cosgrove et 
al., 2010).  The importance of assisting patients to overcome the pragmatic barriers to 
appointment attendance is highlighted by the finding of quality of life being positively 
related to appointment attendance.  Participants’ quality of life was found to be 
significantly correlated with appointment adherence.  Participants with higher quality of 
life attended more appointments than participants with lower quality of life.  The clinical 
significance of the quality-of-life finding should be taken into consideration during 
treatment planning with patients.  For example, mental-health providers could highlight 
the importance of appointment attendance with their patients, and they could reinforce 
good attendance rates.  Furthermore, appointments could be scheduled at times when 
patient attendance is most viable, and appointments should be scheduled at a frequency 
that would likely fit into each patient’s life.  Such an individualized treatment approach is 
aligned with recovery-oriented treatment principles.   Previous research found that people 
who did not attend their mental-health appointments had decreased social functioning, 
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had more severe psychiatric symptoms, were more socially impaired, and had 
significantly increased chances of having been admitted to a psychiatric hospital in the 
past year than did those who attended their appointments (Killaspy et al., 2000).  
Additionally, patients who missed their appointments after their initial visit were more 
functionally impaired and overall more unwell than patients who attended appointments 
(Killaspy et al., 2000).   
Missing appointments could also be considered a warning sign that the patient 
might be experiencing symptom exacerbation or other aversive consequences of their 
mental illness.  Previous research supports the notion that missed mental-health 
appointments can be indicative of deteriorating psychiatric health and that the overall 
quality of life of the patient is declining (Mitchell & Selmes, 2007).  As one would 
expect, symptom severity was found to be significantly negatively correlated with quality 
of life, which means the more severe symptomatology the participants were experiencing, 
the lower the quality of life they reported.  Apparently, people who attended more 
appointments reported higher quality of life, even if they were experiencing exacerbation 
of their symptoms.  People may be less negatively affected by their symptoms when they 
attend appointments.  Perhaps they have a stronger sense of mastery over their 
symptomatology, and they feel supported when they regularly visit with their treatment 
providers. 
Inconsistent outpatient attendance is problematic in numerous fields of healthcare, 
in addition to mental-healthcare (Coldham et al., 2002).  Adherence has been noted to be 
a multiply determined construct with related barriers, such as transportation, childcare, 
being underinsured, financial constraints, lack of knowledge regarding the healthcare 
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system, fragmented communication among healthcare professionals, and interference in 
functioning from positive symptomatology (Fenton, Blyler, & Heinssen, 1997).  While 
some individuals in the current sample gave qualitative answers that indicated some of 
these pragmatic barriers, such as transportation issues, many other barriers to 
appointment attendance might already have been addressed and worked out with the 
current provider.  
 Individuals perceiving their treatment as recovery-oriented may function 
differently from other people with regards to their appointment attendance.  Scoring high 
on measures of recovery may mean that attending regular appointments is critical to 
maintaining their recovery.  The individuals in the current study may also have been 
farther along in their recovery journeys or stages; however, this possibility could not be 
confirmed with the current study design.  The scales used to measure the recovery 
orientation of the treatment providers were analyzed to determine any associations among 
them.  The Empowerment (POW) scale was found to be significantly correlated with the 
Attitudes toward Treatment scale (ATT) scale, the Recovery Assessment Scale-Short 
Form (RAS-SF), and the Participatory Decision Making Scale (PDMS).  As people’s 
ratings increased regarding how empowered they felt relating to their perspective on life 
and having to make decisions, their attitudes toward treatment, recovery assessment, and 
perception of involvement they are with their psychiatric treatment decisions also 
increased.  POW was also found to have a significant correlation with quality of life, 
meaning that the more empowered participants considered themselves to be, the higher 
quality of life they reported, thus confirming findings in previous literature (Corrigan, 
Kleim, Vauth, & Wirtz, 2007). 
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Medication adherence and appointment attendance have been found to have 
significant interactions (Dolder et al., 2004).  People with schizophrenia who are 
nonadherent to their treatment are likely more symptomatic, which makes them less 
capable of attending to their medical and physical needs, including attending medical 
appointments.  Other behaviors that promote poor health can be assumed to occur more 
frequently in those who are less adherent to mental-health treatment and are therefore 
more symptomatic (Dolder et al., 2004).  The current study found appointment 
attendance to be significantly positively correlated with medication adherence quality and 
frequency, although the directionality of these relationships could not be established 
because of the cross-sectional nature of the design of the study.  People who may not take 
their medication as prescribed may also not attend their mental-health appointments, 
which may lead to their dropping out of mental-health treatment altogether. 
Quality of Medication Adherence 
The recovery model examined in the current study was not determined to be 
significantly predictive of quality of medication adherence.  The lack of significant effect 
is likely related to the long average length of treatment of the participants by their current 
providers.  Previous research supports the theory that beneficial treatment effects of 
antipsychotic medication are usually delayed for some time after the start of 
administration (Oehl et al., 2000); therefore, this sample likely experienced the benefits 
of the medication more saliently than the side effects. 
Most of the variance in participants’ quality of medication adherence was 
predicted by attitudes toward psychiatric treatment, as measured by Attitudes Toward 
Psychiatric Treatment (ATPT) scale.  The quality of medication adherence outcome 
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variable was found to be significantly positively correlated with the ATPT scale, 
indicating that people who reported having positive attitudes toward psychiatric treatment 
also reported that they adhered well to their medication regimen.  This attitudinal scale 
seems to have strong predictive validity regarding medication adherence behavior, which 
is an important finding with clinical implications.  Patients can be educated regarding 
psychiatric medication, and their attitudes toward the medication can be an ongoing part 
of their treatment.  Previous research has also found the patients’ level of acceptance of 
their medication regimens to be the most important factor in determining the 
effectiveness of their treatment (Fenton, Blyler, & Heinssen, 1997).   
The independent variables were tested separately for their predictive validity with 
regards to the quality of medication adherence variable.  The current analysis found that 
the POW scale was correlated with quality of medication adherence.  The more 
empowered participants rated themselves, the more adherent they considered themselves 
to be with their medication regimens.  
Study participants generally scored high on the measures of how recovery-
oriented they perceived their treatment to be.  The results suggest that individuals’ 
concepts of being in recovery differ in meaning with regards to how well they believe 
they adhere to their medication.  Some people may attribute successful recovery to taking 
psychotropic medication.  Conversely, other people may believe that since they are doing 
well with their recovery, they do not need to take their medication.  The construct of 
empowerment can be thought of with regard to the relationship between the aspects of 
treatment people consider as important to their recovery.   
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Frequency of Medication Adherence 
The variables that were conceptualized to measure the recovery orientation of the 
treatment were not found to be predictive of medication adherence frequency.  The long 
length of treatment that the participants had been receiving from their treatment providers 
possibly did not allow for enough variance in the self-report ratings of the recovery 
orientation of the providers.  The participants in the current study generally reported high 
levels of medication adherence.  Research has found that only about one third of people 
with schizophrenia are fully adherent to their medication regimens (Oehl et al., 2000).  
Mitchell and Selmes (2007) found that 75% of people discontinue taking their 
antipsychotic medication in the first year of being prescribed a new prescription.  This 
finding suggests that the closer to onset of the psychotic disorder, the more nonadherence 
tends to be problematic.  Given the average length of treatment was more than eight 
years, the participants in the current study represented a population farther away from the 
time they were first prescribed medications for their mental-health problems.  When 
compared to the average medication nonadherence rates for the population of people with 
schizophrenia (one-third non-adherent), the participants in the current study on average 
have higher self-reported levels of medication adherence. 
Additionally, these participants were likely people who tended to have high levels 
of adherence in general.  The sample examined in the current study did not have a large 
number of missed appointments.  These participants likely had been prescribed many 
different types of psychotropic medication throughout their years of receiving treatment, 
and they likely were more aware of which medications were successful for treating their 
unwanted symptoms and which medications they could tolerate the best.  They might also 
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have been more stable in their treatment and less likely to discontinue their medications 
because of side effects.  Such factors would make this particular sample more likely to 
adhere to their medications (Coldham et al., 2002).  Addressing side effects has a large 
potential implication for treatment effectiveness.  Previous research has identified 
patients who had undesirable side effects alleviated by medication changes after they 
reported their experience to their physicians (Lambert et al., 2004).  The patients who 
experienced a direct change in their treatment after participating in the decision process 
with their physicians reported significantly more positive attitudes toward psychiatric 
treatment than did those who did not have these experiences (Lambert et al., 2004).  The 
current study found attitudes toward psychiatric treatment to be the single most important 
finding with regard to medication adherence.  Therefore, direct attempts should be made 
to improve patients’ attitudes toward treatment, and the result is likely to be 
improvements in their medication adherence behavior.  Additional research has also 
demonstrated positive outcomes regarding patients’ medication adherence when their 
families are included in the psychoeducation process (Resnick et al., 2005).  The ATPT 
scale was developed to address participants’ outlooks toward taking psychiatric 
medication.  This scale was found to be significantly correlated with each of the predictor 
scales and both of the medication outcome variables (frequency and quality).  
Participants who reported a higher frequency and quality of taking medication as 
prescribed also reported having more positive attitudes toward psychiatric medication.   
The RAS-SF was also found to be significantly correlated with the ATPT scale.  
People who rated themselves as having positive attitudes toward psychiatric medication 
also significantly reported high scores on the recovery assessment measure, and they 
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reported positive attitudes toward treatment.  For certain people, having positive attitudes 
toward psychiatric medication may be part of their recovery.   
Participants’ scores on the ATT scale, which was adapted from the coercion scale, 
were found to be significantly correlated with ATPT scores.  Participants who reported 
that they did not believe they were coerced into mental-health treatment and that they had 
positive attitudes towards treatment also reported having positive attitudes toward 
psychiatric medication as part of their mental-health treatment. 
POW was found to be significantly positively correlated with ATPT scores.  
Therefore, people who generally felt empowered tended to have positive attitudes toward 
psychiatric medication, which is consistent with previous research findings (Deegan & 
Drake, 2006; Dickerson, 1998).   
Based on the large amount of variance in the medication outcome variables that 
the ATPT scale accounted for, measuring and addressing patients’ attitudes toward 
psychiatric medication is important if medication is a recommended part of their 
treatment.  If someone’s goal is to become independent from medication, this goal should 
be taken into consideration as part of his or her recovery.  Otherwise, keeping people on 
medication when medication is not personally important to them is an unrealistic 
expectation on the part of the treatment provider.   
The positive correlation with ATPT scale and the PDMS suggests that the more 
the participants believe they are involved with their psychiatrist during the decision- 
making process regarding their medications, the more they have positive attitudes toward 
taking psychiatric medication. This evidence provides further support for the idea that 
people want more involvement in their treatment as part of their recovery.   
RECOVERY MOVEMENT AND TREATMENT ADHERENCE 76 
The Recovery Model and Service Engagement 
The recovery model has multiple theoretical relationships with service 
engagement beyond simply taking medications and attending appointments with 
psychiatrists.  Although the intention of the current study was to measure treatment 
adherence through those indicators, the larger implications for mental-health treatment of 
individuals with severe mental illness include more broad service engagement 
considerations.   
Service engagement may be antithetical to certain individuals’ concept of 
recovery.  By definition, being in recovery with a mental illness is a highly individual 
process.  Some individuals with serious mental illnesses may view recovery as a process 
that does not involve traditional medical treatment components.  On the other hand, other 
individuals may decide that minimal engagement in treatment is a goal of their recovery.  
For example, their goal might be to become stable on medication so that they can have a 
job, to attend an occasional psychiatry appointment during which they do not have to 
participate in decisions, and to simply take the medication as prescribed and live an 
uninterrupted life.  People who reported positive attitudes toward psychiatric treatment 
also reported high levels of quality of life.  For many participants in the current study, 
high quality of life was indicative of people wanting to have or having more involvement 
with their mental-health treatment. 
Perhaps people feel that being highly involved with their treatment is a sign that 
they have a sense of mastery over their treatment and their symptomatology; therefore, 
they are able to feel that their overall quality of life is positive, even if they experience 
symptoms.  This explanation is aligned with the principles of the recovery model, in that 
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recovery is an individualized process and being rid of symptoms is not always the goal of 
each patient.   
Predicting a construct that is as multiply determined as treatment adherence is 
difficult. Service engagement is a much more complicated construct than simply 
adherence to medication and attending scheduled appointments.  The quality of the 
interaction between the service provider and the patient, the extent to which the patient 
views the treatment as helpful and important, and the degree to which patients 
incorporate treatment principles into their daily living are additional concepts that should 
be included in measures of service engagement.  Although the outcome of the current 
study was measured by appointment attendance and medication adherence, the intention 
was more broadly to examine barriers to service engagement and the clinical implications 
that can be gained.   
Many individuals consider some self-care activities to be part of their treatment, 
and these activities should therefore be considered part of service engagement.  For 
example, some people include alternative treatments, yoga and other forms of exercise, 
prayer, meditation, and nutrition as part of their treatment.  Participants from the current 
study answered the question regarding engagement in other meaningful activity with 
“church” (N = 6), “art” (N = 3), “day program/clubhouse” (N = 3), and “childcare” (N = 
1).  A barrier to people including alternative forms of treatment and self-care into their 
regimen is that health insurance reimburses only for certain types of treatment (more 
traditional forms of treatment).  Health insurance barriers also present problems for 
measuring service engagement because people’s concepts of what is considered part of 
treatment are partially defined by what is reimbursed as part of healthcare, even though 
RECOVERY MOVEMENT AND TREATMENT ADHERENCE 78 
researchers and clinicians know healthcare involves more than medication and attending 
appointments (i.e., behavior change, nutrition, quality time spent with others, additional 
self-care activities). 
Models for conceptualizing healthcare behavior exist, including adherence-related 
concerns.  The most prominent of these theories include the health belief model, theory of 
reasoned action, protection motivation theory, and subjective expected utility theory 
(Ronis, 1992; Weinstein, 1993).  Common assumptions among theories are that people 
anticipating negative health outcomes will increase their motivation to engage in health-
protective behaviors, that their perception of the likelihood that the negative outcome will 
occur affects their motivation, and that peoples’ motivation to engage in health-protective 
behaviors increases as their expectation that their action will reduce their likelihood of 
being harmed increases (Weinstein, 1993).  The current study found that when people 
have self-reported symptom exacerbations, they are likely perceiving their mental illness 
as more threatening, which can be a motivating factor to attend their scheduled 
appointments.  Furthermore, the health belief principle regarding the connection between 
the belief that a particular treatment will help alleviate symptoms and adherence to the 
treatment was evident in the current study.  The ATPT scale measures the extent to which 
people believe their psychiatric medication will help; therefore, the more they are 
confident in their medication’s effectiveness, the more they should adhere to their 
medication regimen, which was confirmed by the results of the current study.  Treatment 
implications that are linked to the health belief models are that patients should be 
educated regarding the potential benefits of their treatment and the potential harm that 
their symptoms can cause. 
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Generally, the participants reported high on the measures of recovery.  For 
example, the mean scores for each Likert scale of the recovery scales were in the agree 
range, meaning the participants generally agreed that they felt free to choose to be in 
treatment, that they felt empowered, and that their treatment was recovery-oriented.  
Possibly, most participants were generally satisfied with their treatment, thereby limiting 
the amount of variance in their responses on the measures of the independent variables.   
Sociocultural Considerations 
The current study was conducted in Philadelphia at four service agencies that 
largely serve an urban underserved population.  This sampling also means this population 
is likely impoverished, which raises questions regarding how to assist people in 
becoming more empowered, especially when their surroundings are so demoralizing.  For 
example, people living in these neighborhoods likely experience daily life challenges, 
such as housing concerns, easy access to illegal and legal substances, and lack of jobs, 
that are disempowering, so when they come to treatment, expectations for them to 
become empowered are unrealistic without improving these other aspects of their lives  
(Draine, Salzer, Culhane, & Hadley, 2002).  
Cultural considerations regarding the desirability of being empowered should be 
considered.  Being empowered for some people might mean having faith that their 
treatment provider makes good decisions for them and that they should simply comply.  
Cultural differences could determine how much empowerment an individual expects or 
even wants in his or her life.  A cultural norm could make questioning of the treatment 
provider unacceptable, especially for those in poor urban communities who are 
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disempowered in so many other ways.  Higher rates of appointment nonadherence have 
been found in urban areas for people with severe mental illness (Compton et al., 2006).   
One question regarding culture from the Staff Relationships scale asks the 
participants to complete a Likert scale regarding their psychiatric treatment and culture: 
“My psychiatrist is not sensitive to my cultural needs.”  This question was found to be 
significantly correlated with the ATPT scale, POW scale, PDMS, RAS-SF, and 
medication adherence quality.  Therefore, participants who considered their psychiatrist 
to be more sensitive to their cultural needs also reported that they adhered to their 
medication, had more positive attitudes toward psychiatric medication, felt more 
empowered, had higher levels of participation with their treatment decisions, and rated 
higher on the recovery assessment measure.  The clinical significance of cultural 
sensitivity has been found to be pronounced, and cultural sensitivity is theoretically 
linked as part of the recovery model.  When the question regarding culture was entered to 
control for any possible confounding effects in the regression analysis, some of the 
variance in the model was significantly accounted for regarding the medication adherence 
quality outcome; however, the recovery model remained insignificant for predicting the 
adherence on all three of the outcome measures.  
Limitations 
There were several limitations to the current study.  The first limitation is related 
to the use of an archival data set.   Limitations associated with using archival data include 
not having access to the participants or the clinicians to gather any qualitative data or to 
follow up with them regarding aspects of their treatment and adherence issues.  
Furthermore, the reliability of the participants’ self-reports may be questionable.  The 
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current researcher also did not have access to the mental-health treatment centers where 
the interviews were conducted and the treatment was being implemented; therefore, we 
could not assess differences among the treatment centers or the quality of the treatment 
the participants were receiving.  These aspects of limited access to the methods of data 
collection become problematic for replicating the current study.  Previous research 
identified variables that can significantly affect treatment adherence, which the current 
researcher did not have access to, including issues regarding mandated treatment, history 
of sexual abuse, measures of hope and advocacy concerns, education available to the 
participants regarding treatment options, impaired insight, poor social functioning, poor 
premorbid functioning, and history of inpatient hospitalization (Glynn et al., 2006; 
Kreyenbuhl et al., 2009; Swartz et al., 2003). 
Another limitation is that the independent and dependent variables were measured 
by self-report items.  The participants could have been seeking a positive reaction from 
their treatment providers, or their estimates of adherence to their treatment could have 
been influenced by numerous individual factors.  The average length of treatment for the 
participants was more than 8 years.  This length of treatment could be reflected in the 
participants’ view of the treatment facility, which was likely more positive than those of 
people who are new to a treatment facility.  Most of the participants rated their treatment 
as having generally high quality.  These ratings were likely affected by the long length of 
time they had been receiving services from the same treatment facility.  There was not 
much variability in the participants’ reports of satisfaction with their treatment provider.  
There was likely a homogeneous population of people who were included in the current 
study with regards to the geographic location and the long average length of treatment, 
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therefore limiting the amount of variance in the dependent variables and limiting the 
generalizability of the findings.  Additionally, the questionnaire was lengthy, and the 
participants could have been experiencing fatigue.  Symptoms of their mental illness 
could have affected the participants’ ability to endure the length of the interview and 
answer the questions accurately. 
The questions in the interview protocol that were chosen to measure the outcomes 
of medication adherence and appointment attendance could have presented limitations in 
their semantics.  For example, the question measuring medication adherence quality was 
not specific as to which type of medications or which type of physician prescribed the 
medication.  Therefore, primary-care physicians, emergency departments, or inpatient 
psychiatric facilities may have prescribed antipsychotic medication that was unusual for 
the participants’ regimen.  Such changes could have complicated their ability to follow 
the medication prescription.  An additional potential effect of the broad scope of 
interpretation of this question includes, participants having medical conditions for which 
they do not fully adhere to medication.  If that were true, participants would likely 
include such consideration when answering the quality of medication adherence 
questions because the question does not specify solely psychiatric medication.    
The current study design ran preliminary analyses on variables that had been 
found in previous studies to correlate with the dependent variables in the current study, 
and only the variables that were found significant were used as control variables in the 
main analysis, thereby making the results less generalizable to the larger population.  
Another limitation related to using archival data is that the theoretical constructs 
that were used to measure how recovery-oriented a treatment is perceived were not part 
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of the original study.  Therefore, the methodology for measuring the recovery model was 
not ideal.  Furthermore, the measurement for treatment adherence was not included in the 
aim of the original study for which the data were gathered.  The same limitation is then 
true for the dependent variables in the current study, which is that they were chosen to 
measure a construct because they were the best fit given the predetermined set of 
questions.   
A limitation relating to the recovery model and the constructs that are considered 
to be essential parts of the model also was found.  Two of the guiding principles of 
recovery-oriented treatment according to SAHMSA include recovery being culturally 
based and influenced and being supported by addressing trauma (SAMHSA, 2012).  The 
archival data set used in the current study did not include data regarding the participants’ 
trauma histories because the questionnaire did not include questions regarding this topic 
when the data were gathered.  While some cultural data were gathered in the original 
study, too many data points were missing for too many participants, and hence, these data 
were not used at all in the current analysis.  Further studies on recovery-oriented 
treatment affecting treatment adherence should include measures for both trauma history 
and culturally informed treatment.  Also, peer support and family involvement, which are 
important recovery principles, were not measured.  
Another area of limitation is related to the correlational nature of the data 
analysis.  No causality can be determined from the implications of this research because 
there was no manipulation of the independent variables.  The data can be analyzed only 
to determine if relationships between the variables exist.   
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Limitations related to the measures of the dependent variables also were found.  
The two questions that were chosen to measure medication adherence were theoretically 
determined to measure two separate aspects of medication adherence: quality and 
frequency.  The quality-related question asked the participants “how well” they currently 
take their medications.  The question is nonspecific to psychiatric medication, while the 
question addressing medication adherence frequency is specific to “antipsychotic 
medication.”  Furthermore, the frequency of medication adherence question broadens the 
time frame being evaluated by expanding from “current” to “over the past four months.”  
These two questions were analyzed to determine the overlap between these two related 
constructs.  Medication adherence quality and frequency were found to be positively 
correlated, r (213) = .466, p < .01.  The study design also has limitations related to its 
generalizability.  For example, the data collection was limited to four community mental-
health centers in the Philadelphia area.  The demographics of the participants were not 
especially diverse.  The socioeconomic status of the participants was likely similar, 
considering the location and type of treatment centers they were attending.  
Recommendations for Future Research 
Suggestions for replicating the study include obtaining attitudinal and 
observational data from clinicians and using fidelity checks during the interviews and 
data collection.  Some examples include a more comprehensive range of ethnicities, 
participants who have received services from multiple agencies or are new to the mental-
health system, and people with different diagnoses.  A review of participants’ charts 
could be conducted to gather supplemental objective adherence data (i.e., record of 
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appointment attendance, lab results regarding medication compliance, notes on 
participation in alternative forms of treatment and self-care). 
Also recommended is that future research explore provider-related constructs in 
association with service engagement.  Issues related to provider mistrust, therapeutic 
alliance, and patients believing their opinions are taken into consideration by the 
treatment provider have all been found to significantly affect treatment adherence and, 
therefore, significantly affect treatment outcomes.  However, most of the existing 
research is focused on patient-related factors.  Clinical implications might be more salient 
in the provider-focused research since treatment providers tend to have more control over 
the factors affecting the providers than they do over patient-related barriers to care.   
Cultural considerations should be explored in future research, especially with 
regards to the extent to which people want to be involved in treatment decisions.  Given 
the current findings regarding PDM, certain sub groups of patient populations likely 
prefer to have trust in their providers and desire the ability to have minimal involvement 
in their treatment.  Collectivistic and individualistic cultural differences could account for 
some of the difference in desire to have a more inclusive treatment approach versus a 
more paternalistic approach.  The mainstream American culture may tend to assume 
having participatory treatment is more desirable.  However, the evidence from the current 
study suggests that this assumption may not be universally applicable. The findings do 
suggest that people’s attitudes toward psychiatric medication are one of the most 
important factors to be considered with regards to people’s likelihood of adhering to the 
prescribed regimen.  Clinical decisions should take into account people’s personal goals, 
even if those goals include not depending upon medication.  Urban and rural populations 
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should be studied given the evidence that urban populations with severe mental illness 
seem to have larger nonadherence problems than rural populations.  Perhaps evidence 
that differentiates rural treatment from urban treatment can inform treatment in urban 
cultures to improve their outcomes.   
 A study of the effects of recovery-oriented treatment on service engagement 
would be better conducted if the data were gathered specifically for that purpose.  Service 
engagement could be measured more validly if additional questions were included to 
measure treatment adherence and service engagement or if scales that have been 
validated to measure these constructs were used as the dependent measures.   
 The recovery framework has been gaining attention as a model for the treatment 
provision for individuals with severe mental illnesses, and it is being increasingly 
investigated in research.  However, advocacy for the model could include its benefits for 
people with other types of mental illness.  The recovery model is gaining attention in 
treatment of only severe mental illness and could therefore become viewed as 
stigmatizing the population it is aimed to serve.  By definition of the recovery model, 
each individual could benefit from its principles, regardless of mental-health status.   
 Future studies should also consider gathering qualitative data (in addition to 
quantitative data) to measure the recovery principles because of the suggested importance 
of the individualistic nature of recovery-oriented treatment.  For example, the participants 
could be asked to state their goals and the extent to which they believe their treatment is 
supportive of their goals for recovery.  This qualitative information would supplement the 
quantitative data from the scales and could answer some of the questions that were 
RECOVERY MOVEMENT AND TREATMENT ADHERENCE 87 
proposed during the interpretation of the current study (e.g., Do people want to be 
involved in the decision-making process regarding their antipsychotic medication?).   
By definition, recovery is supposed to be unique and individualized for each 
person, so this definition presents a challenge regarding how to build a system of service 
that works well for most people.  Treatment facilities seem to be adopting the recovery 
framework  and attempting to provide services that would meet a broad range of 
preferences for their patients, and including exercise, computer courses, recovery goals 
(not limited to treatment goals), including family in the treatment.  These alternative 
aspects of individualized treatment should be measured in future studies of the recovery 
model. 
 The current study was conducted with the intention to determine if recovery 
aligned constructs are related to increased engagement in treatment for individuals with 
schizophrenia spectrum disorders.  Although the model for measuring recovery-oriented 
services was not predictive of medication adherence or appointment attendance, some 
useful findings discussed.  If the model had been found to be significantly predictive of 
service engagement, the utility for mental-health treatment would be aimed at increasing 
the degree which the recovery model is guiding treatment.  The current findings do not, 
however, suggest otherwise.  The findings do suggest that measuring recovery-oriented 
services and service engagement is a complicated task that is likely worth further 
investigation.  The definition of recovery challenges people to think about treatment on 
an individual level, which suggests that research on the model needs to take individual 
preferences and variations into consideration.  Possibly, qualitative research may be a 
more appropriate fit for this this conceptualization. 
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 The findings also suggest that quality of life and symptom severity are 
significantly related to attending appointments.  People seem to believe their lives are 
more worth living when they experience fewer symptoms and attend mental-health 
appointments.  Clinical decisions regarding frequency of appointments and patients’ 
ability to attend those appointments should be considered along with the patients’ 
recovery goals. 
Given the quickly developing digital age, research and treatment need to keep up 
with available technology to help people access and adhere to the available forms of care 
(Cosgrove et al., 2010). 
Treatment engagement is a topic in need of further investigation.  Previous 
research suggests that increasing treatment adherence is the single most direct way to 
eliminate symptom exacerbation and to improve overall outcomes for people with 
psychotic disorders (Coldham et al., 2002); however, engagement remains problematic.    
The psychiatric literature suggests that increased engagement for the overall population 
of individuals with serious mental illnesses is an important societal issue (decreased 
psychiatric symptoms, violence, homelessness, hospitalizations, and healthcare costs).  
These outcomes are likely important for the population receiving the services and could 
possibly be considered when developing their recovery goals. 
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